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Chapter 1 
INTRODUCTION 
Allylic phosphorus reagents are extremely useful intermediates for the synthesis 
of conjugated dienes and polyenes. Ylides derived from allylic phosphonium salts have 
been utilized in industry extensively for the synthesis of retinoids and carotenoids.1 On 
the other hand, in spite of their potential utility, allylic phosphonates have seen very little 
use as reagents for the synthesis of conjugated dienes2'3 and polyenes.4-8 
The Wittig reaction9 of ylides derived from allylic phosphonium salts (1)10 with 
an aldehyde or ketone (2), gives a conjugated diene, (3) also a trisubstituted phosphine 
oxide ( 4), which is usually difficult to separate from the desired olefin (below). 
2 
---+ R 
2 
3 4 
In contrast, the Horner-Wadsworth-Emmons reaction (HWE)11 of an allylic 
phosphonate12 (5) with an aldehyde or ketone (2) produces an identical conjugated diene 
(3) accompanied by a water soluble phosphate anion (7) that is easily separated from the 
reaction mixture (next page). 
5 2 
., R 
2 
2 
3 7 
In addition to the ease of isolation of products from the HWE reaction, greater 
control of the olefin stereochemistry is observed. The Wittig reaction of an ylide derived 
from an allylic phosphonium salt and an aldehyde or ketone often produces mixtures of 
the (£)- and (Z)-alkenes. Predominance of the (E)-alkene can be accomplished via 
stabilization of the phosphorus ylide, salt-free conditions, or via (3-oxo-ylides.13 In 
contrast, under the standard conditions of the HWE reaction of phosphonates with 
aldehydes or ketones, the (E)-alkene is usually the major product. 
Since allylic phosphonates offer a number of advantages over the corresponding 
allylic phosphonium ylides, their limited use in synthesis is surprising. There are two 
reasons that allylic phosphonates have had limited use in synthesis. First, the allylic 
halide precursors are often unstable under the reaction conditions required for formation 
of the phosphonates.14 Second, an electron withdrawing group is often necessary in the 
a- or y- position to allow formation of the carbanion under relatively mild conditions.12 
If the electron withdrawing group is not a desired feature of the final product, functional 
group conversion is required. 
The most common approach to the synthesis of allylic phosphonates (9) is the 
Arbuzov reaction, which involves the displacement of a halide from an allylic halide (8) 
3 
by a trialkyl phosphite.15 
XS 
(RObP + 
R2 X 
+ R2 P(OR)2 I 
R1 R1 o, 
R 
8 
l 
0 
II 
R2 P(ORh + RX 
R1 
9 
Two features limit the use of the Arbuzov reaction in the formation of HWE precursors. 
First, substitution in the Arbuzov reaction can take place at either the a- (11) or y-
position (12) in the allylic halide as is the case when the corresponding allylic 
phosphonium salts are formed. 16 y-Substitution in the Arbuzov reaction is especially 
prevalent with internal allylic halides.17 
~~x ~o tt:ty (RObP II (RO)2P ~R2 P(OR)2 + R2 
R1 R1 R1 
10 11 12 
4 
Second, the trialkyl phosphite can function as a Lewis base, thereby causing loss of the 
stereochemical integrity of the allylic carbon-carbon double bond. 
In an effort to circumvent attack at they-position, Salzer and co-workers attempted 
to react conjugated diene-iron carbonyl complexes (13) with trialkyl phosphites.18 
13 
1.P(OEth 
2. NaHCO3 
14 
Although Salzer obtained regioselective attack at the less substituted end of the 
conjugated diene the reaction was not stereoselective, providing a diastereomeric mixture 
of allylic phosphonates (14). 
An alternative approach to the Arbuzov synthesis of phosphonates is the 
Michaelis-Becker reaction, in which an allylic halide (15) is reacted with an alkali metal 
derivative of a dialkyl phosphite (16). 19 
16 
R,Y~(OR), 
R1 
17 
5 
Unfortunately the Michaelis-Becker reaction suffers from the same drawbacks as the 
Arbuzov reaction namely, y-position substitution, loss of stereochemical integrity of the 
allylic double bond, and also elimination reactions.20 
A number of alternatives to the Arbuzov and Michaelis-Becker reactions have 
appeared in the literature for the formation of the allylic phosphonates. Zhu and Lu have 
reacted allylic phosphites (18) with NiC12 to synthesize allylic phosphonates (19, 
20)[below ].21 
+ Diene 
18 
The rearrangement is not regiospecific providing both a- (19) and y-phosphonates (20). 
In addition, nickel catalyzed rearrangement competes with an elimination reaction to give 
a dialkyl phosphite and the corresponding diene. In the case of the allylic phosphites 
derived from 2-cyclohexen-1-ol, 1,3-cyclohexadiene, the elimination product, is formed 
exclusively with no formation of the corresponding phosphonate. The rearrangement of 
allylic phosphites has also been attempted using Ni(cod)/2 providing similar results. In 
a later paper, Lu and Zhu reacted dialkyl phosphites (22) with ally! acetates or carbonates 
(21) in the presence of Ni( cod)2 in a preparation of allylic phosphonates (23).23 
21 
X = R or OR 
R1,R2 = alkyl or aryl 
22 
5 mol % Ni(cod)2 
Base/THF 
O-
Ii 
R,~P(OR~2 
R2 
23 
6 
Initial attempts using triethylamine as base in the above reaction produced the desired 
allylic phosphonates in low yield. However, substitution of bis(trimethylsilyl)acetamide 
(BSA) as base provided the allylic phosphonates in moderate to good yields. 
Bodalski and Janecki have synthesized allyl phosphonates by thermally induced 
Arbuzov rearrangement of preformed trialkyl phosphites.24 
24 
(Et0)2PCI 
Et3N / Et20 I ..,....0XR11 (EtO),P R, 70 - 100"C 
25 
The trialkyl phosphite is synthesized from the corresponding allylic alcohol (24) and 
diethyl phosphorochloridite to avoid possible competing reactions encountered in the 
traditional Arbuzov reaction of trialkyl phosphites and alkyl halides. The crude 
7 
intermediate is heated to induce rearrangement to the desired allylic phosphonate (25) in 
good yield. The stereoselectivity is dependent on the nature of R2• When R2 = CO2CH3 
the reaction affords exclusively the (Z)-olefin whereas when R2 = CN a mixture of (E)-
and (Z)-olefins is produced. 
Hirao and co-workers have utilized a palladium-catalyzed synthesis of 
phosphonates from alkyl halides and dialkyl phosphites.25 The reaction of aryl and vinyl 
halides using this methodology produced the desired phosphonates in moderate to good 
yields. As an extension, Hirao and co-workers attempted to synthesize an allylic 
phosphonate (28) from a conjugated diene using tetrakis(triphenylphosphine)palladium as 
a catalyst with 1,2-bis(diphenylphosphino)ethane (DIPHOS) and isoprene (26). 
Unfortunately the reaction proceeded in only 10% yield. 
0 
II 
HP(OEt)2 
Pd(PPh~4 
DIPHOS 
0 y~(OEt)2 
26 27 28 
In a later paper Hirao and co-workers, in an attempt to synthesize cyclopropyl 
phosphonates (30) via Arbuzov reaction of substituted cyclopropyl bromides (29) and 
trialkyl phosphites, discovered that the corresponding allylic phosphonate (31) had been 
produced by ring cleavage. 26 
8 
R H 
R H k;j + P(0Et)3 
R1 Br 
k;j 
R1 P(OEt)2 II 
+ 
0 
29 30 31 
It is interesting to note that regardless of the nature of R and R1 the allylic phosphonate 
is formed preferentially from 1.5:1 to 14:1 over the desired cyclopropyl phosphonate. 
Although the number of methods for the regio- and stereoselective synthesis of 
allylic phosphonates is rather small, the variety of reactions these reagents can undergo 
makes them versatile reagents in organic synthesis. Their most important application is 
the HWE coupling reaction between allylic phosphonates and aldehydes or ketones to 
provide conjugated dienes in a regio- and stereoselective fashion. 
Lavielle and Sturtz2 used allylic phosphonates (32) to synthesize a variety of 
functionalized 1,3-dienes (34) in good yield. 
"~ l ~ (R0)2P ...,_,..... ~ X + Base X 
R2 
32 33 
X = OR, SR, NR2 
9 
Although no stereochemistry was reported, it is likely that a mixture of (E)- and (Z)-
olefins would be obtained depending on the stereochemistry of the allylic phosphonate. 
Pattenden and Weedon5 have examined the stereochemistry of olefin formation in 
relation to the geometry of the allylic phosphonate. Reaction of trans-4-diethyl 
R 
35 36 37 
R = Ph or 
phosphono-3-methyl-2-butenoate (35) with either benzaldehyde or (Z)-citral (36) provides 
a product in which the stereochemical integrity of the double bond in the allylic 
phosphonate has been maintained. Reaction of the cis-4-diethylphosphono-3-methyl-2-
butenoate with either aldehyde gave only 25% of the desired cis-ester, the remainder 
being trans-ester (37) owing to stereomutation during the reaction. 
Allylic phosphonates have also been used extensively in the synthesis of insect 
biomolecules. Corey and co-workers have synthesized the juvenile hormone from 
Hyalophora Cecropia21'28 as well as, the dehydro derivative29 utilizing the allylic 
phosphonate ester, (35) as illistrated in the equation shown below. 
10 
C02CH3 
+ Base 
--.. ~ 
P(0Et)2 II 
0 
38 35 
41 
Edwards and co-workers have utilized a similar allylic phosphonate ester ( 42) to 
synthesize the fungal sex hormone trisporic acid.8 Although the target molecule was 
isolated as the all trans isomer, ( 44) no explanation for the stereocontrol is given. 
I 0 c 
OHC~ 
NaH 
THF 
42 43 
Trisporic acid 
44 
11 
As mentioned previously, allylic phosphonates have seen limited use as carotenoid 
precursors due to inherent difficulties in formation, although some examples have 
appeared in the literature. Surmatis and Thommen reacted retinyl allylic phosphonate ( 45) 
with retinal to provide trans-(3-carotene in 61 % yield based on recovered retinal.30 
1. Lindlar catalyst 
2. NaOCH3 
trans-j3-Carotene 
3. Retinal 
45 
Liu and Asato have reacted methyl trans-4-diethylphosphono-3-methyl-2-butenoate (35) 
with an aldehyde to provide two isomeric retinoids ( 48). 4 
... 
CHO 
NaH 
+ 
THF 
46 35 
48 
12 
The resulting mixture of 7-cis, 9-cis and 7-cis, 9-cis, 13-cis retinoids is not in accord with 
earlier reports of Pattenden and Weedon that showed the configuration of the trans double 
bond in the allylic phosphonate to be maintained in the products. The authors did not 
offer an explanation for this discrepancy. 
Allylic phosphonates have also been shown to react with Michael acceptors in 
conjugate addition reactions. Modro and co-workers31 have synthesized a variety of 
acyclic (54) and cyclic (52) phosphonates via the lithiated salt of diethyl prop-2-enyl 
phosphonate (50) (Scheme I). The reaction provides paths to a number of new 
intermediates for further HWE reactions. 
In conclusion, allylic phosphonates are extremely useful reagents for the synthesis 
of conjugated dienes and polyenes but have seen limited use due to few reliable methods 
to provide high yielding and stereoselective syntheses. 
-
13 
Scheme I. Reaction of the lithiated salt of diethyl prop-2-enyl phosphonate. 
0 
Rf: 1 
0 
II B Li 
~P(OEt)2 ~ 
49 
53 
, 
14 
Synthetic Approach - Historical 
Recently Babier and Schlidt32 reported a novel synthesis of all-trans-retinoic acid 
(60). The key step of the synthetic approach involves the isomerization of vinyl 
phosphonate 58 to the corresponding allylic phosphonate 59 (Scheme II). A priori, this 
route did not seem feasible since analogous allylic phosphonium salts are known to 
isomerize to the corresponding vinyl phosphonium salts in the presence of base [i.e., the 
reverse of the boxed equation ].33 In addition, the isomerization of allylic phosphonates 
to vinyl phosphonates has been reported34 using alkali metal hydroxides. The successful 
and novel isomerization of 58 to 59 prompted a further study of the scope of this 
methodology as a possible stereocontrolled approach to allylic phosphonates. 
55 
Scheme II. Synthesis of all-trans-retinoic acid. 
(CHJl 2S=CH2 
o-------
0 
~ II P(OCH2CHs)2 
58 
)=!co,cH,cH, 
OHC 
Base 
MgBr2 
56 
KOC(CHi)3 
60 
R = CH2CH3 or H 
0 
II 
CH2[P(OCH2CH3hb 
CHO B 
ase 
57 
0 
II 
P(OCH2CHs)2 
59 
C02R 
-Vt 
Chapter 2 
RESULTS AND DISCUSSION 
The required vinyl phosphonates35 were synthesized by a modified HWE reaction. 
Condensation of several representative carbonyl compounds (61a-d) with the anion 
derived from tetraethyl methylenediphosphonate (62)36 afforded vinyl phosphonates (63a-
d) in good yield. 
Table I. Synthesis of vinyl phosphonates. 
61 62 
b, R' = CH2Ph; R = H 
Carbonyl Compound 
Isobutyraldehyde (61a) 
Phenylacetaldehyde ( 61 b) 
Heptanal (61c) 
Cyclohexanone (61d) 
a(E) isomer only. 
16 
NaH 
THF 
d, R',R = (CH2) 5 
Yield of 63 
93a 
54 
63 
31P NMR 0 
20.2 
18.8 
19.4 
18.9 
17 
The stereochemical outcome of the synthesis of the vinyl phosphonates is worth noting. 
Vinyl phosphonates (63a-c) were shown to posses the (£)-configuration which was 
confirmed by their 1H NMR coupling constants and 13C NMR analysis.43 
It is interesting that condensation of cyclohexanone (61d) with 62 affords solely 
the exocyclic olefin (63d). Previous attempts37'38 to synthesize vinyl phosphonate 63d 
demonstrated that the initial exocyclic double bond was readily isomerized to the 
endocyclic double bond (73d) under the reaction conditions. 39 
0 0 
II II 
P(OEt)2 P(OEt)2 
63d 73d 
The 1H and 13C NMR shift data and coupling constants were consistent with the structure 
63d; and the 31P chemical shift obtained for 63d (31P o 18.9) was in agreement with those 
obtained for vinyl phosphonates (63a-c) and other reported vinyl phosphonate 31P 
chemical shifts.40 The moderate yield of 63d (54%) is also consistent with the lower 
reactivity of ketones in both the Wittig and HWE reactions. 
Condensation of 62 with 2-butanone (64), 2-heptanone (66) and 2-
methylcyclohexanone (68) provided the tri-substituted olefins 65, 67, and 69, respectively 
(Scheme III). 
18 
Scheme III. Vinyl phosphonate syntheses. 
0 
~ 62 
0 
~II I P(OEt)2 
64 65 
0 
~ 62 0 II P(OEt)2 
66 
0 
0 62 II 
P(OEth 
68 69 
The trisubstituted phosphonates (65 and 69) could then be used to test the regio- and 
stereoselectivity of the isomerization of vinyl phosphonates to allylic phosphonates. 
Reaction of 62 with 2-methylcyclohexanone (68) provides the corresponding vinyl 
phosphonate in 9% yield based on starting material. The 31P NMR contained two peaks 
(31P b 20.1, 18.8) in a 15:1 ratio consistent with the formation of the two possible 
stereoisomers of the vinyl phosphonate 69. 
0 
II 
P(0Et)2 
69a 69b 
Attempts to separate 69a and 69b from starting material using flash chromatography did 
19 
not provide pure fractions of the vinyl phosphonates. Subsequent attempts to improve the 
yield or separate the desired vinyl phosphonates did not succeed. 
The use of 2-heptanone also produced low yields of the desired vinyl phosphonate 
based on starting material (11 %). The 31P NMR also contained two peaks (31P l> 20.0, 
19.2) again consistent with both the (E)- and (Z)-configuration of the vinyl phosphonate 
(67). Attempted purification did not furnish any separation of starting ketone and vinyl 
phosphonate. 
The use of 2-butanone (64) as the carbon electrophile gives rise to four peaks in 
the 31P NMR (31P l> 20.4, 20.0, 19.5, 18.8). The peaks at l> 20.4 and 19.5 in the 31P NMR 
were assigned the (E)- (Z)-mixture of the desired vinyl phosphonate, while those at{> 20.0 
and 18.8 arise from the diastereomeric pair of {3-hydroxy bis-phosphonates (70) the 
intermediate formed in the HWE reaction. 
OH 0 II 
P(OEt)2 
70 
There are four pieces of evidence that support the structural assignment of 
compound 70. The intermediate formed from attack of 62 on 2-butanone (64) provides 
the oxyanion that usually arranges itself cis to a phosphonate group to undergo 
elimination to the alkene and phosphate anion. In both cases when one of the 
20 
phosphonate groups of 62 is cis to the oxyanion, the other is in a highly, energetically 
unfavorable conformation (71, 72). 
71 72 
Both conformations required for the formation of the alkene are of high energy, eclipsing 
of the phosphonate and alkyl group extend the lifetime of the gauche rotomers of the 
intermediate which are both unsuitable for cis-elimination. This resulted in protonation 
of the intermediate oxyanion upon work-up giving the f3-hydroxy bis-phosphonate. The 
1H NMR also shows a doublet of triplets with a large (20.8, 3.4 Hz) coupling constant 
at b 2.6 ppm suggesting a hydrogen flanked by two phosphonate groups. There are two 
additional facts that support the assignment given to structure 70. First, the 31P NMR 
shifts are consistent with those assigned for other f3-hydroxy phosphonates.40•41 Second, 
in an attempt to isomerize the reaction mixture using KOC(CH3) 3 in DMSO the 31P NMR 
peaks at b 20.4 and 19.5 are replaced by peaks downfield, while the two peaks at b 20.0 
and 18.8 remain. This would be consistent with the fact that added base did not produce 
an isomerization reaction of 70. 
In a effort to maximize the yield of vinyl phosphonates 63a-d, the condensation 
of isobutyraldehyde (61a) with tetraethyl methylenediphosphonate (62) was examined 
21 
using several representative bases. As illustrated in Table II, use of NaH in 
tetrahydrofuran (THF) afforded the highest yield of the desired product. 
Table II. Conditions for synthesis of vinyl phosphonates. 
JyH 62 
BASE/ SOLVENT 
ROOM TEMPERATURE 0 
61a 
Base 
NaH 
NaOCH2CH3 
(CH3) 3COK 
K2C03 
K2C03 
Solvent 
THF 
THF 
THF 
THF 
DMSO 
~P(OCH2CH:,)2 II 
0 
63a 
Yield 
95 
47 
26 
38 
18 
Villiras and co-workers42 reported an 89% yield of 63a using heterogenous reaction 
conditions (K2C03, H20, 100° C) although we obtained only 38% using the same base in 
THF. Use of potassium carbonate in a polar solvent such as DMSO, surprisingly, 
afforded a very poor yield (18%) of 63a. This was also surprising because in THF 
potassium carbonate gave a 38% yield of 63a. These results can be attributed to differing 
basicities of potassium carbonate in the two solvents. 
In view of the tendency of allylic phosphonium salts to isomerize to the 
22 
corresponding vinyl phosphonium salts in the presence of base, it was surprising to find 
that vinyl phosphonates (63a-d) isomerized exclusively to the corresponding allylic 
phosphonates (73a-d), when treated with a catalytic amount of potassium tert-butoxide 
in DMSO (Table III). The structural integrity of each isomerized product (73a-d) was 
verified by 31P NMR analysis. 
The stereochemical outcome of the isomerizations in Table III is also worth 
noting. All vinyl phosphonates prepared as discussed previously were shown to possess 
the (£)-configuration by 1H NMR and 13C NMR analysis. Spassov and co-workers43 
have shown that the 3Jc-P coupling constants for vinyl phosphonates are stereodependent. 
The 3Jc-P for cis-isomers is between 6.9-11.0 Hz while trans-isomers show 18.3-25.7 Hz 
coupling constants. Vinyl phosphonates (63a-c) showed 3Jc-P coupling constants of 21.0 
Hz, 23.0 Hz, 22.0 Hz, respectively, suggesting that they are of the (£)-configuration. In 
addition, 31P NMR spectra for all vinyl phosphonates contained a single peak. The 
corresponding allylic phosphonates also proved to be of the (£)-configuration based on 
1H NMR coupling constants and 31P NMR data. In only one of the isomerizations (63b 
-+ 73b) was any (Z)-isomer detected in the reaction product. When 63b was treated with 
a catalytic amount of potassium tert-butoxide at 20 °C for 5 hours, 1H NMR analysis 
indicated that the corresponding allylic phosphonate was a 24/1 mixture of E/Z 
stereoisomers. Isolation of the major diastereomer gave a 1H NMR spectrum identical to 
that of the (£)-isomer reported in the literature.48 However, when the reaction time was 
extended to 24 hours no (Z)-isomer was observable by either 1H NMR or 31P NMR 
analysis. 
Table III. Isomerization of vinyl phosphonates to allylic phosphonates 
Vinyl 
Phosphonate 
63a 
63b 
63c 
63d 
R"' 
R"~i(OCH,CH,), 
R 
(CHs)3COK 
DMSO 
63 
Isomerization 
Product 
~P(OCH,CH,J, 
II 
0 
~ji(OCH,CH,J, 
0 
~P(OCH2CHs)2 II 
0 
0 
II 
~P(OCH,CH,J, 
a (24:1) E:Z mixture. b E stereoisomer only 
R'" 
R"Yi(OCH,CH,), 
R 
73 
Yield of Allylic 
Phosphonate (73) 31p NMR {> 
85 29.1 
928 27.4 (E) 
28.7 (Z) 
66b 28.5 
84 28.8 
N 
VJ 
24 
The isomerization of the vinyl phosphonate (65) to the allylic phosphonates 74 and 
75 (as previously discussed) afforded a complex mixture of products. 
0 0 0 
~II (CH;J)COK I P(OEth -□-M_S_O_ ~~{OEt),, ~II I P(OEt)2 
65 74 75 
Formation of the allylic phosphonates was evidenced by the downfield appearance of 
three new peaks in the 31P NMR. The 31P NMR chemical shifts were 29.4, 29.0, 28.5 
indicating the formation of 74 and the two stereoisomers of 75. 
Hine and co-workers44 have derived the "double bond stabilization parameter" a 
quantitative measure of the migration of a double bond in a 1,3-disubstituted propenyl 
system in relation to the effect of X and Y on the stability of the alkene function. 
76 
XHC=CH-CH2-Y 
77 
Recently,45 Wagener and Modro have examined the prototropic equilibrium of some 
diethyl alkenylphosphonates (78) [vinyl phosphonates] in their double bond stabilization 
ability. The authors found that in a t-BuOH/t-BuOK system that the equilibrium in most 
cases gives exclusively the allylic phosphonate (79). 
25 
0 0 
II II 
P(OEt)2 P(0Et)2 
78 79 
The authors showed that in their system vinyl phosphonate 63a converts to a 99/1 mixture 
of allylic phosphonate (73a) to vinyl phosphonate (63a) at equilibrium. Also vinyl 
phosphonate (63d) converts exclusively to the allylic phosphonate (73d) at equilibrium. 
This data provides a theoretical explanation for our observed formation of allylic 
phosphonates, though the authors provide no stereochemical information for the products. 
Table IV presents the results of a limited study to assess the conditions required 
for this isomerization. It is apparent from the yields in this study that the basicity of the 
tert-butoxide in DMSO46 plays a crucial role in the isomerization of vinyl phosphonates 
to the corresponding allylic phosphonates in this investigation. 
Table IV. Conditions for isomerization of allylic phosphonates. 
~P(OCH2CH,)2 II 
0 
63a 
Base 
(CH3)JCOK 
NaOCH2CH3 
K2CO3 
K2COJ18-Crown-6 
K2COJ18-Crown-6 
BASE 
SOLVENT 
ROOM TEMPERATURE 
Solvent 
DMSO 
DMSO 
DMSO 
DMSO 
THF 
~P(OCH2CH,)2 II 
0 
73a 
Yield 
85 
9 
0 
0 
0 
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Chapter 3 
CONCLUSION 
In conclusion, we have developed a novel and reliable regio- and stereospecific 
synthesis of allylic phosphonates from the corresponding vinyl phosphonates. In addition 
to the facility with which each of the utilized transformations occurs, the exclusive 
formation of (E)-stereoisomers points to the use of the allylic phosphonates (73) as 
versatile intermediates in the stereoselective synthesis of dienes and polyenes. 
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Chapter 4 
EXPERIMENTAL 
General Methods. 1H, 31P, and proton-decoupled 13C NMR spectra were recorded at 300 
MHz, 121 MHz and 75 MHz respectively. 1H and 13C NMR spectra were recorded in 
deuterated chloroform (CDCl3) and all chemical shifts are referenced to tetramethylsilane 
(TMS) as an internal standard. 13C NMR data includes a listing of coupling constants 
recorded for 31P coupling to 13C. 31P NMR spectra were recorded in CDCl3 using 85% 
phosphoric acid as an external standard. Analytical thin layer chromatography (TLC) was 
conducted with aluminum backed silica plates. Flash chromatography was performed on 
Kieselgel 60, 230-400 mesh. Aldehydes were distilled directly before use, and all other 
solvents were purified according to standard literature procedures. The spectral properties 
of all vinyl and allylic phosphonates were minimally consistent with 1H NMR data 
reported in the literature. When 13C and 31P NMR data was available for comparison, this 
was used as additional confirmation of the structure of products. 
General synthesis of vinyl phosphonates (63). The ylide was generated under a 
nitrogen atmosphere by dropwise addition of 1.2 mmol of tetraethyl 
methylenediphosphonate (62)36 in 2 mL THF to a stirred solution of 1.1 mmol of sodium 
hydride in 2 mL THF, maintained at a temperature of 15-20 °C by use of an external cold 
water bath. Subsequent addition of a solution of 1.0 mmol of aldehyde in 3 mL THF was 
28 
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followed by stirring of this reaction mixture for an additional 0.5 h at room temperature. 
The mixture was then diluted with ether and extracted in successive order with 7:3(v/v) 
lM aqueous NaOH:methyl alcohol (2 x 30 rnL) to remove excess diphosphonate, 1:l(v/v) 
H2O:brine (1 x 30 mL) and brine (20 mL). The organic layer was dried over MgSO4, and 
the solvent removed in vacuo to afford the vinyl phosphonates as colorless oils after 
evaporative (Kugelrohr) distillation. 
General synthesis of allylic phosphonates (73). Vinyl phosphonate (1 equiv.) and 0.25 
equivalent potassium tert-butoxide were stirred in anhydrous dimethyl sulfoxide (2 mL 
per mmol of 63) for 24 h. The mixture was subsequently diluted with ether and extracted 
with 10% aqueous NaCl (2 x 25 mL) and brine (20 mL). The organic layer was then 
dried over MgSO4, and the solvent removed in vacuo to afford the allylic phosphonates. 
Flash chromatography to separate stereoisomers of 73b on silica ( diethyl ether) afforded 
the pure (E)- and (Z)-73b. 
(E)-(3-Methyl-l-butenyl)phosphonic acid diethyl ester (63a): bp 141 °C (bath 
temperature, 0.25 mmHg); Rf= 0.73 (diethyl ether); 1H NMR b 6.79 [ddd, lH, J = 16.0, 
12.3, 6.0 Hz, H-C(2)], 5.61 [m, lH, H-C(l)], 4.09 [m, 4H, POCH2], 2.48 [m, lH, H-
C(3)], 1.35 [t, 6H, J = 7.0 Hz, POCH2CH3], 1.08 [ d, 6H, J = 6.9 Hz, CH3-C(3)]; 13C 
NMR b 159.7 [d, J = 4.0 Hz, C(2)], 113.0 [d, J = 188.0 Hz, C(l)], 61.6 [d, J = 5.6 Hz, 
POCH2], 32.5 [d, J = 21.0 Hz, C(3)], 21.1 [CH3-C(3)], 21.0 [CHrC(3)], 16.4 [d, J = 6.4 
Hz, POCH2CH3]; 31P NMR b 20.2. 1H NMR data were consistent with that previously 
reported for this compound and confirmed the absence of the corresponding (Z)-
stereoisomer, 1H NMR data of which has been published.37•38 
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(3-Methyl-2-butenyl)phosphonic acid diethyl ester (73a): bp 134 °C (bath temperature, 
0.3 mmHg); Rr = 0.67 (diethyl ether); 1H NMR b 5.45 [m, lH, H-C(2)], 4.06 [m, 4H, 
POCH2], 2.53 [dd, 2H, J = 22.0, 7.2 Hz, H-C(l)], 1.74 [d, 3H, J = 5.7 Hz, CH3-C(3)], 
1.65 [ d, 3H, J = 4.5 Hz, CH3-C(3)], 1.29 [t, 6H, J = 7.0 Hz, POCH2CH3]; 13C NMR b 
137.1 [d, J = 14.8 Hz, C(3)], 113.2 [d, J = 11.1 Hz, C(2)], 61.7[d, J = 6.7 Hz, POCH2], 
26.4 [ d, J = 140.0 Hz, C(l)], 25. 7 [CH3-C(3)], 17.9 [CH3-C(3)], 16.4 [ d, J = 6.0 Hz, 
POCH2CH3]; 31P NMR b 29.1. 1H, 13C and 31P NMR data were consistent with those 
previously reported.18 
(E)-(3-Phenyl-1-propenyl)phosphonic acid diethyl ester (63b). bp 206 °C (bath 
temperature, 0.3 mmHg); Rr = 0.74 (diethyl ether); 1H NMR b 7.37-7.20 [m, 5H, 
phenyl], 6.95 [m, lH, H-C(2)], 5.66 [dd, lH, J = 17.4, 1.8 Hz, H-C(l)], 4.10 [m, 4H, 
POCH2], 3.58 [d, 2H, J = 6.3 Hz, H-C(3)], 1.35 [t, 6H, J = 7.2 Hz, POCH2CH3]; 13C 
NMR b 151.5 [d, J = 5.3 Hz, C(2)], 138.0, 137.2, 128.8, 128.6, 128.5, 126.6, 118.1 [d, 
J = 187.0 Hz, C(l)], 61.7 [d, J = 5.6 Hz, POCH2], 40.4 [d, J = 23.0 Hz, C(3)], 16.4 [d, 
J = 6.3 Hz, POCH2CH3]; 31P NMR b 18.8. 1H NMR data were consistent with that 
previously reported. 47 
(E)-(3-Phenyl-2-propenyl)phosphonic acid diethyl ester (73b ): bp 221 °C (bath 
temperature, 0.05 mmHg); Rr = 0.71 (diethyl ether); 1H NMR o 7.40-7.20 [m, 5H, 
phenyl], 6.55 [dd, lH, J = 16.0, 5.3 Hz, H-C(3)], 6.18 [m, lH, H-C(2)], 4.17 [m, 4H, 
POCH2], 2.79 [ddd, 2H, J = 22.0, 7.5, 1.3 Hz, H-C(l)], 1.34 [t, 6H, J = 6.3 Hz, 
POCH2CH3]; 13C NMR o 136.7, 134.5 [d, J = 15.0 Hz, C(3)], 128.6, 128.5, 128.1, 127.5, 
126.1, 118.7 [d, J = 12.0 Hz, C(2)], 62.2 [d, J = 6.6 Hz, POCH2], 31.0 [d, J = 140.0 Hz, 
31 
C(l)], 16.5 [d, J = 6.0 Hz, POCH2CH3]; 31P NMR o 27.4. 1H NMR data were consistent 
with that previously reported for the (E)-isomer.48 
(Z)-(3-Phenyl-2-propenyl)phosphonic acid diethyl ester (73b): bp 219 °C (bath 
temperature, 0.1 mmHg); Rr = 0.68 (diethyl ether); 1H NMR o 7.31 [m, SH, phenyl], 
6.56 [dd, lH, J = 13.4, 4.8 Hz, H-C(2)], 6.20 [m, lH, H-C(3)], 4.15 [m, 4H, POCH2], 
3.88 [m, lH, H-C(l)], 3.61 [m, lH, H'-C(l)], 1.37 [t, 6H, J = 5.8 Hz, POCH2CH3]; 13C 
NMR o 132.7, 129.7 [d, J = 28.1 Hz, C(3)], 128.6, 128.5, 127.3, 126.2, 126.1, 104.1 
[C(2)], 63.8 [POCH2], 28.6 [d, J = 202.2 Hz, C(l)], 16.5 [d, J = 6.0 Hz, POCH2CH3]; 
31P NMR o 28. 7. 1H NMR data were consistent with that previously reported.26 
(E)-1-0ctenylphosphonic acid diethyl ester (63c): bp 171 °C (bath temperature, 0.4 
mmHg); Rr = 0.79 (diethyl ether); 1H NMR o 6.80 [ddd, lH, J = 17.1, 11.0, 5.0 Hz, 
H-C(2)], 5.65 [dd, lH, J = 18.7, 4.1 Hz, H-C(l)], 4.08 [m, 4H, POCH2], 2.22 [m, 2H, H-
C(3)], 1.45 [m, 2H], 1.34 [t, 6H, J = 7.1 Hz, POCH2CH3], 1.31 [m, 6H], 0.90 [t, 3H, J 
= 7.0 Hz, H-C(8)]; 13C NMR o 153.8 [d, J = 4.4 Hz, C(2)], 116.6 [d, J = 187.4 Hz, 
C(l)], 61.5 [d, J = 5.5 Hz, POCH2], 34.2 [d, J = 22.0 Hz, C(3)], 31.3, 27.5, 27.4, 22.4, 
16.4 [d, J = 6.4 Hz, POCH2CH3], 14.0 [C(8)]; 31P NMR o 19.4. 1H NMR data were 
consistent with that previously reported.49 
(E)-2-0ctenylphosphonic acid diethyl ester (73c): bp 163 °C (bath temperature, 0.3 
mmHg); Rr = 0.69 (diethyl ether); 1H NMR o 5.59 [m, lH, vinyl-H], 5.41 [m, lH, 
vinyl-H], 4.10 [m, 4H, POCH2], 2.54 [ ddd, 2H, J = 19.5, 6.8, 4.8 Hz, H-C(l)], 2.04 [m, 
2H], 1.32 [m, 6H], 1.31 [t, 6H, J = 7.1 Hz, POCH2CH3], 0.90 [t, 3H, J = 7.0 Hz, H-C(8)]; 
13C NMR o 136.1 [d, J = 17.0 Hz, C(3)], 118.5 [d, J = 13.4 Hz, C(2)], 61.9 [d, J = 6.7 
32 
Hz, POCH2], 34.7, 30.6 [d, J = 146.0 Hz, C(l)], 27.5, 27.4, 22.2, 16.4 [d, J = 6.5 Hz, 
POCH2CH3], 13.7 [C(8)]; 31P NMR b 28.5. 1H NMR data were consistent with that 
previously reported. 50 
(Cyclohexylidenemethyl)phosphonic acid diethyl ester (63d): bp 169 °C (bath 
temperature, 0.5 mmHg); Rf= 0.63 (diethyl ether); 1H NMR b 5.36 [d, lH, J = 21.0 Hz, 
CHP], 4.10 [m, 4H, POCH2], 2.65 [m, 2H], 2.27 [m, 2H], 1.71 [m, 6H], 1.35 [t, 3H, J 
= 7.0 Hz, POCH2CH3]; 13C NMR b 167.8 [d, J = 3.0 Hz], 109.2 [d, J = 152.0 Hz, C(l)], 
61.3 [ d, J = 6.9 Hz, POCH2], 39.1 [ d, J = 24.0 Hz], 32.2 [ d, J = 17.6 Hz], 28. 7, 28.0, 
25.9, 16.4 [ d, J = 6.2 Hz, POCH2CH3]; 31P NMR b 18.9. HRMS, calcd. for C11H210 3P 
232.1228, found 232.1228. 1H NMR data were consistent with that previously reported.45 
[(1-Cyclohexenyl)methyl]phosphonic acid diethyl ester (73d): bp 174 °C (bath 
temperature, 0.3 mmHg); Rf= 0.81 (diethyl ether); 1H NMR b 5.61 [m, lH, vinyl-H], 
4.10 [m, 4H, POCH2], 2.50 [d, 2H, J = 24.0 Hz, CH:l], 2.11 [m, 4H], 1.58 [m, 4H], 1.31 
[t, 6H, J = 7.6 Hz, POCH2CH3]; 13C NMR b 135.0 [d, J = 13.0 Hz], 126.5 [d, J = 10.7 
Hz], 61.8 [d, J = 6.6 Hz, POCH2], 39.1, 32.1 [d, J = 162.0 Hz, C(l)], 29.5, 22.9, 22.0, 
16.5 [d, J = 6.1 Hz, POCH2CH3]; 31P NMR b 28.8. HRMS, calcd for C11H210 3P 
232.1228, found 232.1224. 1H NMR and 31P NMR data were consistent with that 
previously reported. 37'38'45 
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PART II 
The Indolizidine Alkaloids 
Chapter 5 
INTRODUCTION 
The 1-azabicyclo[ 4.3.0]nonane skeleton (indolizidine) represents a diverse group 
of compounds isolated from both plant and animal sources. A recent review of the 
literature showed that 25 to 30% of the known alkaloids incorporate the indolizidine 
skeleton in various forms.51 The accepted numbering convention for the 1-
azabicyclo[4.3.0]nonane skeleton is indicated below. 
7 
2 
6 
5 
1-Azabicyclo[4.3.0]nonane 
c>-Coniceine, also known as octahydropyrrocoline or indolizidine, is the parent nucleus to 
a diverse group of alkaloids both structurally and biologically. An overview of the major 
classes of indolizidine alkaloids will be discussed. 
Castanospermine and swainsonine52•53 represent the class of polyhydroxylated 
indolizidine alkaloids. Both molecules are potent glycosidase inhibitors owing to the fact 
that their structures share common features with glucose and mannose, respectively.54 Of 
43 
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all the simple indolizidine alkaloids, castanospermine and swainsonine are the most 
thoroughly studied both synthetically and biologically. Swainsonine shows 
immunomodulator ability and use in cancer chemotherapy.55 Castanospermine is a potent 
inhibitor of glycoprotein processing, which opens application as an antitumor agent,56-60 
antiviral61"65 and especially use as anti-HIV agents.66•67 
HO 
H OH 
HO 
HO 
,,,,.,,,,··· 
Castanosperm ine 
HO 
"'"""""OH 
Swainsonine 
H0111,,,, 
,,,,, 
OH 
OH 
D-Glucose 
OH 
OH 
D-Mannose 
Slaframine52 is an indolizidine that has an unusual substitution pattern, and is the 
etiologic agent of slobber syndrome in dairy cattle. It also has been used as a therapeutic 
agent for the treatment of symptoms of cystic fibrosis.68 
45 
OAc 
Slaframine 
Among the most interesting and diverse class of the simple indolizidine alkaloids 
are those isolated from amphibians. The indolizidines (formerly the gephyrotoxins)69 
contain alkyl chains substituted in a variety of patterns at the 3, 5 and 8 position of the 
1-azabicyclo[ 4.3.0]nonane skeleton. 
I ndol izidines 
R =Hor Alkyl 
R1 = H or Alkyl 
R2 = H or Methyl 
The first molecules isolated in this class contained hydrocarbon chains at the 3 (R) 
and 5 (R1) positions of the indolizidine nucleus. As more molecules were isolated some 
were found to contain sites of unsaturation and hydroxylation in the chains at the 3 and 
5-position. These molecules are also considered as compounds in this class of 
46 
indolizidine alkaloids. The indolizidines (gephyrotoxins) have received considerably less 
attention than other indolizidine alkaloids, but represent challenging target molecules for 
synthetic chemists. 
The focus of this dissertation will be on the preparation of indolizidines and 
methods for substitution at the 3, 5 and 8-position in the indolizidine ring system. 
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Isolation and Biological Activity 
The indolizidines are isolated in minute quantities from the skin of neotropical 
frogs of the genus Dendrobatidae.70-76 The frogs secrete the indolizidine alkaloids as a 
natural defense under stress. These skin secretions have been used as arrow poisons by 
South American natives for decades. 
The characterization of these alkaloids has been extensively reviewed. The 
indolizidines are classified numerically, with values associated to their nominal molecular 
weight as determined by mass spectral analysis ( e.g. 223). When other alkaloids of the 
same nominal molecular weight are identified, letters are attached to each to distinguish 
specific substitution patterns and stereochemistry ( e.g. 223 becomes 223A and 223B). 70 
Because of the small amounts isolated from the natural sources very little is 
known concerning their biological activities. In early investigations, Daly and co-
workers77 showed that indolizidines inhibit the acetylcholine receptor, and are weak 
antagonists of muscarinic receptors. Daly and co-workers 78 also have shown that the 
indolizidines are moderately active inhibitors of the nicotinic acetylcholine receptor ion 
channel in electric eels. More recently, Daly70 has shown that the 3,5-disubstituted 
indolizidines produce long lasting locomotor difficulties following subcutaneous injections 
in mice. In addition, it has also been shown that the inhibition of nicotinic acetylcholine 
receptor ion channels is universal for all indolizidine substitution patterns.70 The receptor 
blocking ability of the indolizidines is probably associated with protonation of the tertiary 
amine at physiological pH. The resulting quarternary ammonium salt would be 
structurally related to the ammonium salt portion of acetylcholine. 
48 
Acetylcholine 
Recently, a 5-substituted indolizidine has been isolated from a previously unknown 
source: a sea tunicate Clavelina Picta.83 Piclavine A contains a dec-2-enyl chain at the 
5-position of the indolizidine nucleus. 
Piclavine A 
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Previous Syntheses 
Synthetic strategies for the preparation of the indolizidines in both racemic and 
optically active forms have been the subject of many recent reports. Several excellent 
reviews covering the syntheses of compounds of this class are available, with updated 
reports appearing regularly in several sources.79-82 In this section, indolizidines that either 
have been prepared or can be easily accessed from the intermediates in this dissertation 
will be reviewed. This section is further divided into common substitution patterns (5-, 
3,5- and 5,8-) that are common to the natural indolizidines. 
Indolizidines 167B and 209D represent the simplest of the substitution patterns 
where there is a sole alkyl group at the 5-position in the nucleus. 
R 
167B R = n-Propyl 
209D R = n-Hexyl 
Jefford and Wang84 carried out an enantiospecific synthesis of 167B and 209D using a 
rhodium(II) acetate catalyzed decomposition of an intermediate diazo-compound (1) as 
a key step followed by hydrogenation (Scheme IV). Polniaszek and Belmont85 reported 
the enantioselective synthesis of 167B and 209D via alkylation of a common amino-nitrile 
intermediate (3) (Scheme V). 
Scheme IV. Jefford synthesis of indolizidine 106B and 209D. 
0 N 0 [H] 
, rA 
COCHN2 
2 
Scheme V. Polniaszek synthesis of indolizidine 106B and 209D. 
H H 
1. LDA/THF 
2. RBr 
3. NaBH4 
R 
3 
1678 
or 
209D 
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Monomerine, a member of the 3,5-substituted indolizidines, has been the focus of 
a large amount of synthetic work. Monomerine is the trail pheromone of the pharaoh ant 
Monomorium Pharaonis. 
Me 
Monomerine 
Although monomerine is not of amphibian origin it is classified with the other 
indolizidines owing to structural similarity. Also, synthetic strategies toward monomerine 
hold important information toward other indolizidine preparations. 
The following discussion will summarize several of the strategies, focusing on the 
pivotal reaction step (Scheme VI). The first synthesis of monomerine (Oliver and Sonnet, 
1974) provided all four possible stereoisomers of monomerine from 2,6-lutidine. The 
synthesis showed unambiguously that the configuration of ( + )-monomerine is 3R, SS, 8aS 
relating to the natural product.86•87 Macdonald reported a stereoselective synthesis from 
a substituted pyrroline and 1,4-dibromopentane.88 Stevens and Lee have employed 
reductive amination of a tetrahydropyridinium salt to a synthesis of ( +/-)-monomerine. 89 
Subsequent enantiospecific routes to monomerine have been effected using hetero Diels-
Alder intermediates,90 alkynylation of 1-acylpyridinium salts,91 asymmetric nitrone 
cycloaddition,92 and recently via a Claisen rearrangement of a-amino acids.93 ( +/-)-
Scheme VI. Pivotal intermediates in monomerine syntheses. 
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Reagents: 1. TiPS-OTf / Et3N; 2. LAH; 3. (ClCO)2, DMSO, Et3N; 4. (EtO)2P(O)CH2C(O)n-Bu, KH; 5. 
10% Pd/C, H2, MeOH; 6. Ph3PBr2; 7. Et3N; 8. Na2CO3 / MeOH; 9. oxalic acid; 10. NaCNBH3; 11. [2+2]; 
12. Et3NHC1; 13. HCl; 14. NaCNBH3; 15. H2, Pt/C, MeOH; 16. ethylene glycol, pTsOH / benzene 
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Monomerine has also been synthesized via a novel 2 + 2 cycloaddition of group IV metal 
imido complexes.94 
Far fewer syntheses of the 3,5-substituted indolizidine 223AB have been 
accomplished, though receiving much synthetic interest. This is surprising because it 
differs from monomerine only in the substitution of a propyl for a methyl group (below). 
Pr 
lndolizidine 223AB 
The first reported synthesis of ( +/-)-223AB appeared in 1980 by Macdonald, and 
followed the synthetic strategy utilized for his monomerine synthesis.95 Following this 
report, the first enantiospecific synthesis of (-)-223AB appeared in 1985 and was 
accomplished from a chiral cyano-oxazolopiperidine synthon.96 A number of reports have 
utilized 1,3-dipolar cycloadditions of nitrones to synthesize indolizidine 223. Brandi and 
co-workers reacted a substituted pyroline N-oxide with a hept-1-en-4-ol followed by 
cleavage and recyclization of the isoxazolidine to provide ( +/-)-223AB.97 In a later paper, 
reaction of N-oxides with methylenecyclopropanes followed by rearrangement of the spiro 
isoxazolines furnished an alternative route to this indolizidine.98 Two stereoselective 
approaches to (+/-)223AB using Mannich condensations have also appeared in the 
Scheme VII. Pivotal intermediates for the syntheses of indolizidine 223AB. 
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literature. Condensation of 3-amino-1-heptanol with glutaraldehyde and cyanide produces 
an intermediate tetrahydro-1,3-oxazine, which is then alkylated, cleaved and recyclized 
to 223AB.99 The intramolecular Mannich condensation of an acyclic precursor followed 
by stereoselective hydride reduction of the resulting iminium ion also has provided 
indolizidine 223AB.100 Kibayashi and co-workers101•102 and Stevens and Lee103 both 
reported syntheses of ( +/-)-223AB, which parallel those previously reported for their 
synthesis of ( +/-)-monomerine, using intramolecular nitroso Diels-Alder reaction, and the 
reductive amination of tetrahydropyridinium salts, respectively. Since 1990, only two 
reported syntheses of indolizidine 223AB have appeared. The eight epimers of 223AB 
have been synthesized from a common chiral synthon via cyclic sulfates by Kibayashi and 
Machinaga. 104 An enantioselective, ruthenium promoted synthesis of 223AB from an 
amino-alcohol followed by triphenylphosphine mediated cyclization has appeared (Scheme 
VII).1os 
lndolizidine 239AB lndolizidine 239CD 
A structural isomer related to 223AB also has been isolated that contains a 
hydroxyl group on the butyl chain (239CD). Indolizidine 239CD also has a regioisomer 
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where the hydroxyl group is on the propyl chain (239AB) Only one synthesis of the 
isomeric hydroxylated indolizidine 239CD has appeared. The chiral synthon and cyclic 
sulfate method used by Kibayashi in the synthesis of 223AB was extended to provide the 
only synthesis of ( +/-)-239CD to date, and confirmed the regiochemistry. 106 
The 5,8-substituted indolizidines are the most recent to be isolated from the skin 
of neotropical frogs. 76 All of the naturally occurring 5,8-substituted indolizidines bear a 
methyl group at the 8-position of the molecule. In contrast, the 5 position shows an 
amazing variation in both chain length and structure. 
Me 
R 
205A R = (CH2)aC === CH 
207A R = (CH2)aCH=CH2 
209B R = (CH2)4CH3 
235B R = (CH2)aCH = CHCH2CH3 (2) 
235B' R = (CH2)5CH=CH2 
Recently three new R groups have been identified as substituents in 5,8-substituted 
indolizidines,107 but no syntheses of these natural compounds have been reported to date. 
203A R = CH2CH=CHC==CH (Z) 
2330 R = (CH:03CH=CHCH=CH2 (Z) 
2518 R = (CH:03CH=CHCH(OH)CH3 (Z) 
The first reported synthesis of ( +/-)-205A, ( +/-)-207 A and an enantioselective synthesis 
of (-)-209B was accomplished in 1988 by Holmes and co-workers.108•109 Cycloaddition 
of (Z)-alkenylnitrones (4) followed by reductive cleavage of the N-0 bond yields(+/-)-
205A and (+/-)-207A. Use of a chiral hydroxylamine in the synthesis of the (Z)-
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alkenylnitrone provides (-)-209B enantioselectively. The scope of the (Z)-alkenylnitrone 
methodology has been expanded to the synthesis of racemic ( +/-)-235B. 110 
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In a route analogous to their synthesis of (-)-167B, Polniaszek and Belmont utilized a 
methyl substituted chiral acyliminium ion111 to synthesize the intermediate 8-methyl 
amino-nitrite, which following alkylation gave (-)-205A and (-)-235A enantioselectively. 112 
A short (6 steps) asymmetric synthesis of ( + )-209B from pyridine also has been 
reported. 113 In their continuing study of hetero Diels-Alder reactions for the synthesis of 
alkaloids, Kibayashi and Shishido have synthesized (-)-205A, (-)-207A, (-)-209B and(-)-
235B via a intramolecular Diels-Alder reaction of chiral N-acylnitroso compounds.114•115 
The synthetic approaches previously described all were directed towards a specific 
substitution pattern of natural indolizidines. No synthesis reported has provided entry to 
substitution at all three positions (3, 5 and 8) functionalized in natural indolizidnes from 
a common intermediate An approach that allowed functionalization at all three positions 
would be of great value for the synthesis of both natural and unnatural indolizidines. 
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Synthetic Approach - Historical 
The prior sections showed that a broad range of synthetic approaches, toward 
indolizidines are possible but no method has used dianions. The chemistry of dianions 
has recently been reviewed116 showing a broad application to the synthesis of natural 
products. The remote dianion of 4-(phenylsulfonyl)butanoic acid ( 4-PSBA)117 has been 
extensively studied in our laboratory and found utility in four carbon chain extensions, 118 
synthesis of substituted 6-117 and 7-membered119 lactones, and lactams. 120 
Specifically, condensation of the dianion of 4-PSBA (6, formed by reaction of 4-
PSBA with 2 equivalents of BuLi at -78°C) with an aldehyde, ketone or imine (7) 
followed by anhydride-assisted cyclization provides an efficient one-pot procedure for the 
synthesis of lactones and lactams (9). 
0 
6 7 
X = 0 or NR 
2 Buli 
0 
8 
TFAA 
0 
9 
The imines require prior activation with a Lewis acid (BF3-OEt2) before addition of the 
4-PSBA. The 5-phenylsulfonyl lactams were of great interest because they could possibly 
serve as intermediates towards the synthesis of the large number of piperidine and 
piperidine-containing natural products. 121 
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Preparation of b-coniceine122 and (S)-1-hydroxyindolizidine123 via the dianion of 
4-PSBA were subsequently reported. Further application of the remote dianion of 4-
PSBA has provided a route to the 1-azaspiran skeleton of perhydrohistrionicotoxin.124 
OH 
BnO 
o-Coniceine (S)-1-Hydroxyindolizidine 1-Azaspiran 
In our continued interest in extending the usefulness of the remote dianion of 4-
PSBA, we desired to develop methodology for the synthesis of alkyl substituted 
indolizidines. Our primary goal was to provide a simple route to a common intermediate 
that would furnish a wide variety of substituents at the 3-, 5- or 8-position of the 
indolizidine nucleus from a common intermediate. 
Retrosynthetically (Scheme VIII), we hypothesized that the lactam 10 used for the 
synthesis of b-coniceine could provide the pivotal intermediate necessary for manipulation 
to any substitution pattern occurring in an indolizidine. The phenylsulfonyl provides a 
useful functional group for introduction of an alkyl chain at the 8 position. Reductive 
alkylation could be accomplished with base and the appropriate alkyl halide. 
Alternatively oxidative desulfonylation with bis(trimethylsilyl)peroxide125 affords the 
ketone at the 8 position allowing tremendous possibilities for exploitation to the alkyl 
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chain required in the indolizidines. The Iactam carbonyl although difficult to 
functionalize can be modified to a more reactive intermediate. Reaction of the lactam 
carbonyl with Lawesson's reagent126 to give the thiolactam followed by reductive 
alkylation127 would furnish the alkyl chain at the 5 position. The ease of these particular 
manipulations will also allow entry into indolizidines with more complicated alkyl 
substituents. 
Scheme VIII. 
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Initial attempts proved that manipulations of the 3- and 8-position in lactam 10 were very 
straightforward. Functionalization of the 5-position (lactam carbonyl) proved to be 
extremely difficult. These results prompted the altering of the pivitol intermediate to one 
were 5-position substitution was more facile. Our studies showed that vinylogous 
carbamate 11 would provide improved access to 5-position substitution while, not altering 
established routes to substitution at the 3 or 8-position. 
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Chapter 6 
RESULTS AND DISCUSSION 
The first objective of the synthesis was to prepare the achiral lactam 10, an 
intermediate used for the synthesis of c>-coniceine. 1,4-Butanediol (12) (Scheme IX) was 
protected as its monobenzyl ether (13) using excess diol (KOH, benzyl bromide)128 in 
91 % yield based upon the benzyl bromide consumed. The yield of this reaction was 
increased to 99% by incremental addition of both the KOH and benzyl bromide to the 
diol. The monobenzyl ether (13) was oxidized to the aldehyde (14) [pyridinium 
chlorochromate (PCC)] 129 in 67% yield. Some difficulties in isolation of the products 
from the black tar produced during the oxidation probably reduced the yield. It was 
found that by first filtering the reaction mixture through a Florisil packed funnel, 130 
followed by removal of solvent and column chromatography, increased the yield to 80%. 
Substitution of pyridinium dichromate131 (PDC) improved the yield to 90% in conjunction 
with an alternative elutant in flash chromatography. Swem oxidation132 using dimethyl 
sulfoxide (DMSO) and trifluoroacetic anhydride (TF M) did not prove to be better than 
PDC, providing the aldehyde in 71 % yield. 
Conversion of aldehyde (14) to the acyclic imine (15) was accomplished by 
addition of 14 to a stirring solution of benzylamine in toluene followed by decanting the 
organic layer and drying over barium oxide at -4 °C for 12 hours. The imine is unstable 
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Scheme IX. Synthesis of achiral lactam. 
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and used without further purification in the condensation with the dianion of 4-PSBA (6). 
The dianion of 4-PSBA is first formed by the addition of 2 equivalents of butyllithium 
(BuLi) in THF to provide the characteristic gold color of the dianion intermediate. In 
a separate flask, the imine, dissolved in THF, is activated with boron trifluoride etherate 
(BF3-OEt2) at -78 °C for 30 minutes. The activation, presumably results in the formation 
of a Lewis acid iminium salt which undergoes attack by a nucleophile more readily. The 
intermediate dianion addition product is then cyclized to the lactam by addition of TFAA. 
TFAA 
10 
0 
8 16 
The cyclization reaction is very sensitive to the time between dianion reaction and 
addition of TF AA. If the reaction is allowed to continue for longer than five minutes 
before addition of TFAA, the reaction yields were much lower. The lower yields are 
probably due to rearrangement of the resulting dianion to a more stable dianion wherein 
the secondary anionic site is at the alpha carbon of the phenylsulfonyl as opposed to the 
nitrogen center. Lactam (10) is isolated as a mixture of fast and slow diastereomers 
(based on their normal phase chromatographic elution order) in 82% yield after 
purification. 
The products contain two chiral centers providing two sets of enantiomers. These 
products are obtained in approximately a 1:2 ratio of fast to slow diastereomer. The 
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predominate isomeric mixture (10; slow band) has been assigned the cis stereochemistry, 
which exists as conformations 17 and 18 (Figure 1), where the phenylsulfonyl and alkyl 
substituents are situated axial and equatorial. The other isomeric mixture (10; fast band) 
is then the trans configuration where the phenylsulfonyl and alkyl chains are situated 
diaxial (20), or diequatorial (19) in the ring. 
Figure 1. Chair conformation of achiral lactam. 
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The stereochemical assignment is based on 1H NMR coupling constants (J) between Ha 
and Hi,, examination of models, and comparison to calculated J values from Karplus 
curves.133 In 17 and 18, when the two groups are cis, the angle 8 between Ha and Hi, is 
approximately 60°, and should exhibit a relatively simple 1H NMR spectrum with a 
theoretical JHaHb of 2.5 Hz (accounting for the electronegative phenylsulfone). In contrast, 
when the groups are trans, as is the case for 19 and 20, two angles 8 exist, giving rise 
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to two coupling constants, creating a more complex spectrum. As expected, JHal-lb for the 
slow band was 2.6 Hz while, no single coupling constant could be identified for the fast 
band, although peak overlap was responsible for some of the difficulties in the assignment 
of the fast band. 
Lactam 10 is a desirable intermediate for the synthesis of the indolizidines. The 
lactam contains functional groups at the projected 3-, 5- and 8-positions in the 
indolizidine nucleus that can be simply manipulated to other functional groups. In 
addition, lactam 10 can also be converted to advanced intermediates that offer unique 
opportunities for elaboration. This chapter presents successful approaches to natural 
products that can be accessed by manipulation of the 3-, 5-, and 8-position of intermediate 
10. Also, the effect of substitution at the 5-position on cyclization to the indolizidine 
nucleus was explored. 
Naturally occurring indolizidines show only a methyl group at the 8-position, and 
therefore, we sought to find reliable methods for introduction of this group in lactam 
intermediate (10). Attempts to deprotonate fast 10 using NaH followed by alkylation with 
methyl iodide failed to produce the 8-substituted lactam, giving back starting material 
(fast 10) as confirmed by 1H NMR. Sodium amide and methyl iodide or dimethyl sulfate 
(DMS) as the alkylating agent also gave unreacted starting material. Deprotonation with 
n-BuLi followed by quenching of the anion with DMS successfully produced the 8-methyl 
lactam (21) in 91 % yield. It is surprising that alkylation did not occur alpha to the amide 
carbonyl as the relative pK,.'s are similar for PhSO2CH and the alpha hydrogens of an 
amide. The difference in reactivity may be a consequence of endocyclic (amide) verses 
exocyclic (sulfone) enolate formation, the latter favored for highly substituted rings. 
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Desulfonylation of 21 to the corresponding 8-methyl compound (22) was accomplished 
using sodium amalgam in methanol. Desulfonylation was not accompanied by elimination 
and ring opening to give the alkene which, has been observed in previous synthesis 
toward azaspirans (below ).124 
23 
Na/Hg 
MeOH 
24 
0 
NHBn 
The elimination of 23 may be due in part to added ring strain imparted by the spirocyclic 
system. Compound 22 showed a doublet at b 1.74 ppm (CH3-, 3H) and a multiplet at b 
3.30 ppm (ring CH, lH) in the 1H NMR confirming the presence of the methyl group. 
Two alpha carbonyl protons [-CH2C(O)] remained in the 1H NMR indicating that 
alkylation did not occur at the amide enolate. 
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With methodology in hand for the functionalization of the 8-position, we next 
focused upon the introduction of substituents at the 3-position. Functionalization at the 
3-position requires manipulation of the benzyl ether in lactam intermediate (10). This 
approach intended to introduce a butyl chain at the 3-position because both monomerine 
and indolizidine 223AB have this common substituent at this site. Lactam 10 can be 
chemoselectively de-O-benzylated (10% Pd/C) under H2 ( < 20 psi) to furnish the alcohol 
(25) in 79% yield. Alcohol (25) can then be oxidized to the required aldehyde (26) with 
PCC in 76% yield (Scheme X). 
10 
Pd/ C, H2 
MeOH 
BuMgBr 
THF 
Scheme X. Introduction of 3-butyl chain. 
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The reaction of 26 with n-butylmagnesium bromide in dry ether ( 4 equivalents) proceeded 
poorly to the secondary alcohol (27). Because n-butylmagnesium bromide is unavailable 
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commercially and primary Grignards are somewhat sluggish to initiate, the exact 
concentration of the prepared solution was unknown. Following the reaction, the 1H 
NMR of the crude reaction mixture showed a triplet at o 9.55 ppm suggesting the 
presence of unreacted starting aldehyde. The secondary alcohol (27) was purified by flash 
chromatography to give a 42% yield. 
It was thought that initial removal of the phenylsulfonyl group would facilitate the 
Grignard reaction because an extra equivalent of Grignard would not be required to 
remove the acidic proton alpha to the phenylsulfonyl. The phenylsulfonyl group was 
removed from the lactam (25) using sodium amalgam in methanol to give desulfonylated 
lactam (28). 
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Desulfonylation proved to be a difficult reaction as evidenced by a 13C NMR of the crude 
reaction mixture, which showed a considerable decrease in the relative height of the 
lactam carbonyl peak. The IR spectrum showed the presence of lactam (28) as well as 
hydroxy (29) and amine (30) functional groups, depending on the length of time the 
reaction was carried out. Confirmation of the lactam carbonyl reduction by sodium 
amalgam was made by subjecting 2-pyrrolidone to identical conditions of desulfonylation. 
The 1H NMR and IR spectrum of the reaction mixture indicated the presence of 
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pyrrolidine, which was further confirmed by comparison to an authentic sample. Further, 
the reduction in the lactam system may not be surprising because carbohydrate lactones 
are reduced using sodium amalgam.134 
The complex mixture of products was attributed to the age of the sodium 
amalgam. Other intermediates subjected to desulfonylations also showed an increased 
number of side products when the sodium amalgam used had aged. Due to the necessity 
of a functional group at the 5-position of the molecule to introduce functionality, an 
altered approach to the introduction of the butyl chain was pursued. 
The prior synthesis of (S)-1-hydroxyindolizidine123 showed that a functionalized 
side chain could be introduced into the lactam via reaction of 4-PSBA with y-imino 
ethers. The imino ethers can be prepared from the corresponding lactols. In our 
approach, commercially available y-octanoic lactone (31) was first reduced to the lactol 
(32) in 86% yield using DIBAL-H in ether at -78 °C.135 
Bu n 0 
~o \ 
H 
31 32 33 
The lactol exists in equilibrium with the open chain aldehyde (33). Previous work 
showed the cyclic form predominates in common organic solvents ( ether, hexane, THF, 
CH2Cl2). The aldehyde (33) would be the preferred form for conversion to the imine for 
subsequent condensation with the dianion of 4-PSBA in a one-pot procedure for 
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introduction of the 3-butyl chain. Attempts to protect the free hydroxyl group of 33 
using benzyl bromide produced protected lactol and not protected alcohol. These results 
were not surprising as work reported on the (S)-1-hydroxyindolizidine synthesis 
encountered identical difficulties. As was the case with the synthesis of the (S)-1-
hydroxyindolizidine, the lactol is converted to the hemi-aminal (34) with benzylamine and 
used directly in the dianion reaction with 4-PSBA. 
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The dianion condensation reaction hinges on the existence of a small amount of the open 
chain imine (35) available at equilibrium and changing the equilibrium as the reaction 
proceeds. The TLC of the reaction mixture showed formation of at least eight products. 
This reaction complexity would be consistent with the possible formation of four 
diastereoisomers. In addition, the need of two equivalents of 4-PSBA in the dianion 
reaction further complicates the TLC. The first equivalent removes the proton on the 
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nitrogen of the hemi-aminal and the second effects condensation to form the lactam. The 
crude 13C NMR contained four amide carbonyl peaks consistent with reaction of 4-PSBA 
with the hemi-aminal as well as with the imine. Purification of the reaction provided a 
sample that had a 1H NMR and 13C NMR consistent with the lactam (27) isolated and 
identified from the oxidation-Grignard route previously described (Scheme X). However, 
lactam 27 was isolated in only 14% yield by this method. Therefore, the use of oxidation 
followed by Grignard coupling is a more productive route for 3-position substitution not 
only based on yield but also on the versatility aldehyde 26 could provide in subsequent 
transformations. 
With routes available to 3- and 8-substitution the functionalization of the 5-
position was undertaken. Functionalization of the 5-position is critical to the versatility 
of the intermediate because all natural indolizidines contain a substituent at this position. 
The first method attempted was direct alkylation of the lactam (10) with methyllithium 
followed by reduction of the resulting iminium ion (36) with a hydride reagent136 (Scheme 
XI). As with the Grignard reaction, an excess of base was used because the additional 
alpha phenylsulfonyl acidic hydrogen present in 10 consumed one equivalent of base. 
The reaction produced very little of the mono-methylated amine (38), and the mixture was 
found to contain mostly starting material and reduction product, piperidine (39). Upon 
exposure to air the isolated oil from the reaction, which was initially a light yellow, 
became bright yellow. The change in color was ascribed to oxidation of the amine to the 
N-oxide or hydrolysis of unreacted iminium ion. 137 Therefore attempts to further 
characterize this reaction were thwarted by decomposition. The alkylation of 10 was also 
Scheme XI. Synthesis of 5-methyl piperidine 
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attempted using methylmagnesium bromide but gave similar poor results. Use of 
butyllithium or butylmagnesium bromide instead of methyl analogues also failed to 
produce products. Reactions other than attack at the lactam carbonyl were obviously 
taking place, in particular, the possibility of amide enolate formation was considered and 
shown to be a competing reaction. Evans and co-workers showed that amide enolates of 
lactams can be formed using lithium diisopropyl amide (LDA) and subsequently 
alkylated.138 Confirmation of amide enolate formation was accomplished by reaction of 
10 with 3 equivalents of BuLi and quenching the polyanion with deuterated methanol. 
Analysis of the 1H NMR showed incorporation of deuterium at the alpha position of the 
lactam carbonyl. Last, chromatographic separation of products from the alkylation 
reactions proved to be extremely difficult so alternative methods of introducing an alkyl 
group into position 5 were examined. 
Borch139 showed that amides and lactams could be converted to their imino ether 
fluoroborates and then reduced with hydride to amines. Extension of this methodology 
to the introduction of an alkyl group would use one equivalent of methyl anion followed 
by reduction with hydride. Lactam (10) was converted to its imino fluoroborate (37) 
(Scheme XI) in 80% yield. Compound 37 was converted to the a-methyl substituted 
amine (38) by reaction with 2 equivalents of methyllithium at -78 °C warmed to O °Cover 
1 h, and then 1 equivalent of hydride reagent added. A variety of hydride reagents were 
examined (NaBH4, LiAlH4, NaCNBH3) with the best results obtained with NaBH4• 1H 
NMR showed that in addition to the a-methyl amine and the reduced piperidine (39), it 
was found that a third product was formed. The third product was identified as the gem 
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dimethyl amine ( 40), which is formed by quenching of the initial methyl iminium ion by 
a second molecule of methyllithium. Once again these products were air unstable going 
from light yellow to bright yellow oils upon exposure to the atmosphere. The amount of 
oxidized product in this reaction could be reduced by using ether instead of THF as the 
solvent, but 38 was still isolated in less than 10% yield after chromatography. 
The introduction of the 5-methyl group by reductive alkylation or imino ether 
fluoroborate routes showed marginal promise. Both routes made use of imines to 
accomplish a-functionalization in amine precursors. Logically, reduction of the lactam 
to the piperidine and formation of an imine from the piperidine could provide a direct 
path to a-substitution. A large number of methods exist for the formation of imines ( or 
iminium salts) from the corresponding amines, 140 including a recent review on the 
application of imminium ions to natural product synthesis.111 The modified Polonovski 
reaction of amines (m.-CPBA, trifluoroacetic anhydride) affords the iminium 
trifluoroacetates salts, which can be reacted with nucleophiles to give a-substituted 
amines. 141 Because of the mild conditions and compatibility with a variety of functional 
groups, this method was attempted to functionalize lactam 10. 
The target molecule could be synthesized by borane reduction of 10 to give 
piperidine 39. Desulfonylation furnishes piperidine 41. The reaction sequence was 
carried out on both diastereomers (fast and slow) of 10. Borane reduction of the lactam 
(10) (fast or slow) gave a single product that was composed of diastereomers, resulting 
in corresponding fast and slow diastereomers piperidine (39). Desulfonylation of the fast 
diastereomer gave a single product while the slow diastereomer gave two products by 
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TLC. The two products from the desulfonylation of 10 were determined to be amine 
(41), and 42 the product of ring opening. Identification of 42 was confirmed by the 
appearance of olefinic carbons in the 13C NMR and vinyl protons in the 1H NMR. In 
addition, a similar ring opening was seen in the synthesis of perhydrohistrionicotoxin from 
our laboratory, 124 and in the desulfonylation of other synthetic intermediates in this 
dissertation. 
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It is interesting to note that the single product from the reaction of the fast diastereomer 
is solely 42 while the slow diastereomer provides a 7:3 mixture of 41 and 42. It is 
possible that the fast (trans) diastereomer is predisposed to elimination owing to an anti-
periplanar orientation of the electron pair of nitrogen and the leaving phenylsulfonyl 
group. 
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Because poor yields of the desired amine ( 41) were formed by this sequence of 
reactions, and the electronic environment of the nitrogen in 39 would contribute to ring 
opening, it was decided to reverse the order of reactions. As discussed prior during the 
substitution at the 3-position, it was hoped that the electronic nature of the lactam 
compared to an amine would retard the ring opening seen in the previous desulfonylation. 
Achiral lactam (10), existing as a mixture of both diastereomers, was reacted with 
sodium amalgam in methanol to provide lactam 43 in 89% yield. The progress of the 
reaction could be easily monitored by TLC since loss of the phenylsulfonyl produces one 
spot instead of two diastereomeric spots of the achiral lactam as a result of the removal 
of one chiral center. 
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Borane reduction of 43 gives the amine (41) as the sole product in 95% yield. 
OBn 
Reaction of amine 41 under the conditions of the modified Polinovski reaction 
provided a-substituted amines 44 and 45, following reaction with CN- or CH3Li 
respectively. 
1. m-CPBA 
OBn 2. TFAA 
3. Nu-
41 Nu-= CN or CH3 
Nu 
44 Nu= CN 
45 Nu= CH3 
78 
OBn 
Unfortunately, the use of either nucleophile in the Polonovski reaction consistently 
produced low yields of the respective a-substituted amines 44 (11%) and 45 (17%). 
Two methods to introduce the C-5 methyl via an exocyclic methylene were also 
examined. Reaction of slow lactam (10) with Tebbe's reagent142 failed to introduce the 
methylene group to afford 46. Reaction of 10 with either the ylide derived from methyl 
triphenylphosphonium bromide or dimethyl methylphosphonate also did not provide the 
C-5 methylene compound.143 
PhS02 
Tebbe OBn 
10 
or 
H2C=PPh3 
CH2 46 
It became apparent from these aforementioned studies that introduction of the C-5 
methyl group in our intermediate would be the exception and not the rule. With this in 
mind, it was decided (as discussed in the introduction) to alter the 5-position making it 
more suitable for functionalization while, not altering the 3- or 8-positions. The 
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vinylogous carbamate 11 was chosen for two reasons: 1. the ester offered a suitable 
functional group for homologation and, 2. the synthesis of the vinylogous carbamate from 
10 did not require nucleophilic reagents. 
The Eschenmoser reaction144 has been used extensively for the synthesis of 
vinylogous carbamates from amides and lactams. The reaction enables carbon chain 
extensions from amide or lactam carbonyls, and proved to be valuable in the synthesis of 
polypyrrole alkaloids. The reaction sequences that follow were carried out on both the 
fast and slow diastereomers of lactam 10 [R = PhSO2] and the desulfonylated lactam (37) 
[R = H] unless otherwise noted. For numbering purposes the desulfonylated lactam will 
be denoted by an "H" following the compounds number. 
The lactam 10 is converted to the thiolactam 47 using Lawessons reagent in 96% 
yield (98% R = H).126 Reaction of 47 with ethyl bromoacetate ( 48 hours) followed by 
addition of triphenylphosphine and triethylamine with stirring for an additional 24 hours 
gave the vinylogous carbamate (11) in 94% yield (91 % R = H)[ next page]. 
Unfortunately, attempts to introduce a three carbon chain via the Eschenmoser reaction, 
a decarboxylation sequence using a secondary bromide (ethyl 2-bromobutyrate), did not 
produce any vinylogous carbamate. Shiosaki has reported that secondary halides do not 
react in the Eschenmoser reaction because of steric crowding in the formation of the 
tetrasubstituted olefin.144 
Intermediate 11, now bearing an alternative functional group at the 5-position, was 
subjected to a decarboxylation method in attempts to provide the C-5 methyl group. 
Reaction of 11 and UH with a battery of hydrolyzing reagents, 143 known to decarboxylate 
1 O Lawessons 
or 
43 Toluene 
R 
s 
OBn 
47 
a,(3-unsaturated esters proved to be futile. 
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R 
1. BrCH2CO2Et 
2. Ph3P 
3. E~N 
11 
Because the 5-position now contained an extended functional group, as opposed 
to a carbonyl, the cyclization to the indolizidine was explored. De-O-benzylation of slow 
11 using Pd/C ( <20 psi) in methanol gave back unreacted starting material. Reaction of 
slow 11 using Pd/C, H2 (45 psi) in methanol gave products of de-O-benzylation (48), de-
N-benzylation (49) and bis-debenzylation (50), and the corresponding saturated ester 
derivatives (not shown). 
OH OH 
Pd /C, H2 
11 MeOH + + 
48 49 50 
Hydrogenolysis of slow 11 using a variety of conditions also provided mixtures of 
products (Table V). Because no compound was formed as the major product, a more 
chemoselective method of de-O-benzylation was sought. 
Trimethylsilyl iodide (TMS-1) is known to effect cleavage of a variety of carbon-
oxygen bonds through dealkylation. 146 Specifically, TMS-1 is known to cleave benzyl 
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TABLE V. De-O-benzylation Methods. 
Catalyst Pressurea Acidb Solvent 48 49 50 Saturated 
10% Pd/C B MeOH 
10% Pd/C B + MeOH + + + + 
10% Pd/C p MeOH 
10% Pd/C p + MeOH +c +c +c +c 
10% Pd/C p + EtOH + + + + 
5% Pd/C B + MeOH 
Pd(OH)z/C p MeOH + 
PtO2 p MeOH 
PtO2 p + MeOH 
PtO2 p + EtOH 
( +) = Present; (-) = Absent 
a B = balloon pressure ( < 20 psi); P = Parr shaker ( 45 psi) 
b Approximately 0.20 mL of trifluoroacetic acid (TF A) 
c Reaction also showed products of transesterification 
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ethers at room temperature to give the benzyl alcohol. 147 Because of this 
chemoselectivity, TMS-I cleavage of the benzyl ether of slow 11 was tried. 
OH 
11 
51 
Although cleavage of esters by TMS-I is also a known transformation, it was not a 
concern since elevated temperatures are usually required for the transformation. This was 
confirmed as no ester cleavage was detected in the reaction of 51. In addition, there was 
no evidence of reaction at the double bond of the vinylogous carbamate. Alcohol 51 was 
isolated as the sole product in 81 % yield. The 13C NMR of 51 was compared to that of 
the de-O-benzylated lactam (25), which is structurally related. An upfield shift of the 
carbon alpha to the oxygen and absence of the downfield peak for the methylene of the 
benzyl group (approximately b 70 ppm in 10 and the vinylogous carbamate) indicated 
removal of the O-benzyl group. As additional evidence, a strong absorption at 3485 cm-1 
corresponding to a C-O-H stretch was observed in the IR spectrum. 
Previously, cyclization to the indolizidine has been effected by initial conversion 
of the alcohol to the mesylate, immediate cyclization to the quaternary amine and, 
deprotection of the resulting N-benzyl group. Reaction of vinylogous carbamate 51 
(slow) with mesyl chloride (CH3SO2Cl) showed formation of a new spot with a higher Rr 
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than starting material but no cyclization to the quaternary ammonium compound was 
evidenced (baseline in TLC). It was thought that two factors were hindering cyclization. 
First, the nucleophilic character of the nitrogen in the vinylogous carbamate is lower than 
the piperidines used in prior studies. Second, for cyclization to occur the benzyl group 
attached to nitrogen must adopt a conformation away from the mesyl leaving group, 
which is not possible in the sp2 vinylogous carbamate. Because of this it was decided to 
reduce the double bond prior to cyclization. 
Reaction of vinylogous carbamate 11 with NaBH4 did not show reduction of the 
double bond until the pH was adjusted to approximately 4. Subsequent reactions were 
attempted using NaCNBH3 because this reagent shows enhanced stability at lower pH. 
Reaction of 11 with NaCNBH3 in methanol at pH = 4 gives the piperidine 52 as the sole 
product in 97% yield (97% R = H). At lower pH the vinylogous carbamate is protonated 
at nitrogen decreasing the electron density at the j3-carbon of the ester, thereby allowing 
Michael addition by hydride. At elevated pH, the amine electron donation increases the 
electron density at the j3-carbon of the ester and inhibits attack by a nucleophile. 
R 
OBn 
11 
NaCNBH3 
MeOH, pH= 4 
52 
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In contrast to the reaction of 11 with TMS-1, de-O-benzylation of 52 using TMS-1 
failed to produce the desired alcohol. Upon addition of TMS-1 to 52 a baseline spot was 
immediately detected by TLC, which would be consistent with ammonium salt formation. 
Reaction of 52 with 2 equivalents of TMS-1 also failed to de-O-benzylate the material. 
Hydrogenolysis of 52 at both low and high pressure was attempted, but gave starting 
material and a complex mixture of products, respectively. Because of these results a 
systematic survey of de-O-benzylation reagents was undertaken. Exploratory reactions 
using Raney-Nickel in ethanol to our delight and surprise was found to not only effect 
de-O-benzylation but also de-N-benzylation as well to give 53 (R = PhSO2), with no 
mono-de-benzylated products isolated after 24 h. 
Raney· Ni 
52 -------EtOH 
R 
53 
R 
OH 
54 
The surprising success with Raney-Nickel prompted an exploration into methods that 
would provide a one-pot procedure for the conversion of the vinylogous carbamate (11) 
directly into the deprotected saturated ester (53). The reaction required a large excess of 
Raney-Nickel to accomplish the reductions and showed two side products, which were 
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not seen when the reactions were done sequentially. 
Cyclization of 53 was effected with trifluoromethanesulfonic anhydride, which 
following free-base with triethylamine provides the 8-phenylsulfonyl indolizidine in 70% 
yield. Analysis of the 1H NMR, 13C NMR, IR and combustion analysis confirmed the 
identity of the slow diastereomer of 54. Use of IR is particularly important since 1-
azabicyclo compounds give rise to absorptions called Bohlmann Bands between 2700 and 
2800 cm·1• 146 According to the Bohlmann correlation, an indolizidine will possess one or 
more strong infrared absorptions when two or more hydrogens attached to carbon atoms 
adjacent to nitrogen are oriented trans and diaxial to the nitrogen lone electron pair. 
Indolizidine 54 contains a strong absorption at 2795 cm·1• Combustion analysis of fast 
54 did not provide satisfactory results. Although 1H NMR and 13C NMR analysis showed 
loss of the ethyl group of the ester, the existence of an indolizidine was confirmed based 
on a Bohlmann band at 2790 cm·1• Also interesting was the fact that deprotected 
piperidine 53H did not contain an ethyl splitting pattern in the 1H NMR. The identity of 
these molecules is still being investigated. 
With the indolizidine nucleus complete, elaboration of the ester side chain was 
explored. Attempted reduction of the ester to the corresponding aldehyde with DIBAL-H 
failed to give satisfactory results. Reduction of the ester to the alcohol using LiAlH4149 
(LAH), 2 equivalents of DIBAL-H135 or in situ generation of LiBH4150 failed to reduce the 
ester, probably due to difficulties in control over multiple hydride additions and the 
presence of the phenylsulfonyl acidic hydrogens. Desulfonylation also failed to give 
products. This failure was again attributed to the age of the sodium amalgam used. 
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Preparation of fresh sodium amalgam and desulfonylation of 54 to 55 provided the 5-
substituted indolizidine in 38% yield. 
54 
Na/ Hg 
MeOH 
55 
The isolation of indolizidine 55 as its methyl and not ethyl ester is attributed to 
transesterification during the sodium amalgam reaction. Methoxide is produced in large 
quantities in this reaction as documented in the conversion of phenylsulfone lactones to 
y, b-unsaturated methyl esters. 118 Due to the volatility of the indolizidine, (55) the 
reaction was filtered into acidic methanol to trap the indolizidine as its hydrochloride salt. 
It is also possible that solvent removal under reduced pressure may have caused the 
transesterification to occur. 
Chapter 7 
CONCLUSIONS 
This investigation showed that the remote dianion-cyclization procedure can 
provide a versatile intermediate for the synthesis of indolizidine alkaloids. Moreover, this 
synthetic route has allowed entry into substitutions at the 3-, 5- and, 8-positions of the 
indolizidines from a common lactam intermediate. The Eschenmoser reaction to furnish 
the vinylogous carbamate has further extended the potential of the intermediate by 
providing several possible methods of chain extension for the 5-position. The study has 
also contributed to an understanding of structural and electronic requirements for the 
cyclization of the intermediates to the indolizidine nucleus. 
Future research in this project should include the synthesis of indolizidines 
containing substitution patterns not found in the natural products, synthetic methodology 
for the introduction of non-alkyl functional groups and evaluation of the biological 
activity of these molecules. 
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Chapter 8 
EXPERIMENTAL 
General Methods. 1H and 13C NMR were recorded on a Varian VXR-300 at 300 MHz 
and 75 MHz, respectively. NMR spectra were taken in deuterated chloroform (CDC13) 
and all chemical shifts are referenced to TMS (tetramethylsilane) as an internal standard. 
Infra-red spectra were run on a Perkin-Elmer 1310 spectrometer, and recorded neat (NaCl 
Cells) or as solutions in CDC13 with only the salient bands reported. Analytical thin layer 
chromatography (TLC) was conducted with aluminum backed silica plates (E. Merck). 
Flash chromatography was performed on Kieselgel 60, 230-400 mesh (E. Merck) using 
nitrogen positive pressure. Florisil (Fisher) 100-200 mesh was used where indicated. All 
solvents were purified by standard literature procedures.151 Air and moisture sensitive 
reactions were conducted under a positive argon atmosphere utilizing standard 
techniques. 152 Hydrogenolyses were conducted either with double balloon pressure ( <20 
psi) or in a Parr shaker ( 45 psi). Ethyl bromoacetate (Aldrich) was distilled prior to use. 
Trifluoroacetic anhydride, benzylamine and triethylamine were distilled from CaH2•151 
Triphenylphosphine was recrystallized from hexane151 and 4-PSBA was recrystallized 
from chloroform/diethyl ether. 118 m-Chloroperbenzoic acid was stirred with phosphate 
buffer (pH = 7.6) for 24 h, filtered and, rinsed with ether. 151 All other reagents were 
purchased from Aldrich Chemical Co. (Milwaukee, WI.), and used without further 
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purification. 
0-Benzyl 1,4-butanediol (13).123 1,4-Butanediol (66 mL) was stirred in a flask at room 
temperature to which powdered KOH ( 40 g) and benzyl bromide (20 mL, 168.0 mmol) 
were added in four equal portions over 1 h. After 3 h stirring at room temperature, 100 
mL of H2O was added and reaction extracted thrice with diethyl ether (50 mL). The 
combined organic layers were dried over MgSO4 and the solvent removed in vacuo. 
Column chromatography (4:1, diethyl ether/petroleum ether) yielded 29.9 g of a clear oil 
(99%). Rr = 0.33 (diethyl ether). IR 3430 cm-1 (broad). 1H NMR o 7.35-7.26 (m, 5H), 
4.52 (s, 2H), 3.64 (t, J = 5.9 Hz, 2H), 3.51 (t, J = 5.8 Hz, 2H), 2.39 (s, lH), 1.69 (m, 
4H). 13C NMR o 137.98, 128.29, 127.58, 127.52, 72.99, 70.29, 62.57, 30.07, 26.66. 
4-(Benzyloxy)-butan-1-al (14). 123 4-Benzyloxybutanol (5.0 g; 27.74 mmol) 13 was 
dissolved in 5.0 mL of CH2Cl2 and added to a stirred mixture of PDC (13.64 g; 36.06 
mmol) in 350 mL of CH2Cl2• After 5 h, the mixture was filtered through a funnel 
containing Florisil and the solvent removed in vacuo. Column chromatography (4:1, 
hexane/ethyl acetate) yielded 4.45 g (90%) of a colorless oil. Rr = 0.54 (diethyl ether). 
IR 1710 cm-1• 1H NMR o 9.78 (t, J = 1.5 Hz, lH), 7.35-7.25 (m, 5H), 4.49 (s, 2H), 3.51 
(t, J = 6.1 Hz, 2H), 2.55 (dt, 2H, J = 1.5, 7.0 Hz), 1.95 (m, 2H). 13C NMR o 202.00, 
128.35, 128.29, 127.79, 127.51, 72.94, 69.13, 40.99, 22.64. 
N-Benzylidene-4-(0-benzyl)-butanal (15).123 Aldehyde 14 (2.0 g; 11.22 mmol) was 
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dissolved in approximately 3 mL toluene and was added to a stirring solution of 
benzylamine (1.32 g; 12.34 mmol) in 2 mL toluene. The mixture turned warm and 
became cloudy. After stirring for 2 h at room temperature, anhydrous diethyl ether 
(approx. 5 mL) was added and the organic phase decanted and dried over BaO. The 
mixture was kept at O °C overnight and used without further purification in the dianion 
reaction. Rr = 0.45 (diethyl ether). IR 1670 cm-1• 1H NMR b 7.78 (m, lH), 7.32-7.19 
(m, lOH), 4.53 (s, 2H), 4.47 (s, 2H), 3.50 (t, J = 6.3 Hz, 2H), 2.38 (m, 2H), 1.88 (m, 2H). 
13C NMR b 165.25, 139.10, 136.25, 128.18, 128.10, 127.64, 127.34, 127.27, 126.63, 
72.71, 69.48, 64.88, 32.72, 26.11. 
1-Benzyl-S-(phenylsulfonyl)-6-[3-benzyloxypropyl]-2-piperidinone (10). 123 Imine (15) 
(3.09 g; 11.55 mmol) was dissolved in 11 mL THF. The mixture was cooled to -78 °C 
under argon and freshly distilled boron trifluoride etherate (1.76 mL; 14.44 mmol) was 
added. Concurrently, the dianion of 4-PSBA was generated as follows: 4-PSBA (2.64 g; 
11.55 mmol) was dissolved in 180 mL of THF, cooled to -78 °C under argon, and 18.5 
mL butyllithium (1.2 M in hexane, 23.10 mmol) was added slowly. After 0.5 h, the 
activated imine solution was transfered to the dianion solution via cannula. The gold 
color of the dianion solution quenched immediately, and within 2 minutes trifluoroacetic 
anhydride (TFM) (3.26 mL; 23.10 mmol) was added. The solution was allowed to 
warm to room temperature and 50 mL of ethyl acetate was added. The reaction mixture 
was extracted twice with Na2CO3 (50 mL) and a subsequent brine wash (50 mL). The 
organic layer was dried over MgSO4, filtered, and the solvent removed in vacuo. Flash 
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chromatography (6:4, diethyl ether/ethyl acetate) yielded two products 4.52 g fast and 
slow diastereomers 82% ). 
10 (Fast band): Rr = 0.33 (ethyl acetate). IR 1625 cm-1• 1H NMR b 7.68-7.08 
(m, 15H), 5.49 (d, J = 14.4 Hz, lH), 4.52 (s, 2H), 3.71 (m, 2H), 3.50 (t, J = 6.1 Hz, 2H), 
3.06 (m, 2H), 2. 75 (m, lH), 2.54 (m, 2H), 2.21 (m, lH), 2.03 (m, lH), 1.82 (m, 2H). 13C 
NMR b 169.15, 138.18, 136.34, 133.89, 129.33, 128.70, 128.36, 128.23, 128.03, 127.70, 
127.67, 127.58, 73.13, 69.94, 63.15, 54.64, 50.82, 28.54, 27.90, 27.47, 16.86. 
10 (Slow band): Rr = 0.26 (ethyl acetate). IR 1635 cm-1• 1H NMR b 7.62-7.24 
(m, 15H), 5.29 (d, J = 14.7 Hz, lH), 4.40 (s, 2H), 3.97 (d, J = 14.8 Hz, lH), 3.68 (dt, J 
= 2.6, 9.7 Hz, lH), 3.19 (m, 3H), 2.77 (m, lH), 2.26 (m, 3H), 1.79 (m, lH), 1.59 (m, 
lH), 1.32 (m, lH), 1.21 (m, lH). 13C NMR b 169.29, 137.97, 136.81, 136.45, 133.81, 
129.24, 129.18, 129.05, 128.63, 128.48, 128.34, 127.64, 127.56, 127.50, 73.03, 68.79, 
60.52, 53.45, 48.03, 30.38, 28.90, 25.34, 18. 73. 
1-Benzyl-5-(pheny lsulf ony 1)-5 '-methy 1-6-[3-benzyloxypropyl]-2-piperidinone (21 ). 
Slow lactam 10 (0.313 g; 0.66 mmol) was dissolved in 4 mL of THF and cooled to -78 
0 C. n-BuLi (0.52 mL; 1.2 M in hexane; 0.66 mmol) was added and the reaction was 
stirred for 0.5 h. The -78 °C bath was removed and, dimethylsuflate (DMS) (0.07 mL; 
0.66 mmol) was added and the mixture allowed to warm to room temperature. The 
reaction was extracted twice with NaHCO3 followed by brine. The organic phase was 
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dried over MgSO4, filtered, and the solvent removed in vacuo. Flash chromatography 
(ethyl acetate) yielded 0.296 g of a light yellow oil (91 %). Rr = 0.58 (ethyl acetate). 1H 
NMR b 7.61-7.21 (m, 15H), 5.28 (d, J = 14.8 Hz, 2H), 4.39 (s, 2H), 3.97 (d, J = 14.8 Hz, 
2H), 3.68 (d, J = 9.5 Hz, lH), 3.22 (m, 2H), 2.28 (m, 2H), 2.04 (s, 3H), 1.77 (m, lH), 
1.57 (m, lH), 1.25 (m, 2H). 13C NMR o 169.21, 137.96, 136.80, 136.12, 133.77, 129.14, 
129.01, 128.58, 128.43, 128.29, 127.59, 127.51, 127.45, 72.98, 68.75, 60.49, 53.48, 53.27, 
47.99, 30.34, 28.87, 25.31, 18.68. 
1-Benzyl-5-methyl-6-[3-benzyloxypropyl]-2-piperidinone (22). Lactam 21 (0.149 g; 
0.30 mmol) was dissolved in 3 mL of methanol and 6% Na/Hg was added until TLC 
showed consumption of starting material. After 4 h the reaction was filtered and the 
solvent removed. The residue was taken up in ether and extracted twice with NaHCO3, 
washed with brine, dried over MgSO4 and the solvent removed in vacuo to provide 22 as 
a yellow oil (0.054 g, 51 % yield) Anal. Calcd for CnH29NO2· H2O: C, 74.76; H, 7.91; 
N, 3.79. Found: C, 74.97; H, 8.12; N, 3.94. Rf= 0.51 (diethyl ether). 1H NMR o 7.42-
7.14 (m, lOH), 5.40 (d, J = 14.9 Hz, 2H), 4.49 (s, 2H), 3.92 (d, J = 14.7 Hz, 2H), 3.54 
(t, 2H, J = 6.9 Hz), 3.30 (m, lH), 2.48 (m, 2H), 1.97-1.38 (m, 8H). 13C NMR o 170.11, 
138.19, 137.59, 128.36, 128.26, 127.64, 127.59, 127.45, 126.97, 72.97, 69.76, 55.14, 
47.36, 32.00, 28.82, 26.29, 26.19, 18.07, 17.33. 
1-Benzyl-5-(phenylsulfonyl)-6-[3-hydroxypropyl]-2-piperidinone (25).123 Lactam 10 
(1.23 g; 2.57 mmol) was dissolved in 2 mL THF and methanol was added until the 
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solution became cloudy (approx. 3 mL). The reaction vessel was flushed with argon, 
approx. 50 mg Pd/C was added followed by 0.10 mL trifluoroacetic acid. The mixture 
was stirred at room temperature under H2 ( <20 psi) overnight. Filtration and solvent 
removal in vacuo yielded 0.811 g (82%) of 25 as a clear oil of fast and slow 
diastereomers. 
25 (fast band): Rf= 0.12 (ethyl acetate). IR 3400, 1645 cm·1• 1H NMR b 7.70 
(m, 3H), 7.55 (m, 2H), 7.35 (m, 3H), 7.21 (m, 2H), 5.44 (d, J = 14.5 Hz, lH), 3.80 (m, 
2H), 3.73 (t, J = 5.5 Hz, 2H), 3.15 (m, lH), 2.70 (m, lH), 2.55 (m, 2H), 2.23 (m, lH), 
2.20 (m, lH), 1.77 (m, 4H). 13C NMR b 169.42, 129.40, 128.73, 128.71, 128.25, 128.21, 
63.27, 62.36, 54.51, 50.75, 30.13, 28.59, 27.55, 17.08. 
25 (slow band): m.p. 135-137 °C. Rf= 0.09 (ethyl acetate). IR 3400, 1635 cm·1• 
1H NMR b 7.68-7.22 (m, lOH), 5.22 (d, J = 14.6 Hz, lH), 4.01 (d, J = 14.5 Hz, lH), 3.67 
(dt, J = 2.6, 9.7 Hz, lH), 3.33 (m, 2H), 3.20 (dt, J = 2.4, 6.3 Hz, lH), 2.77 (m, lH), 2.24 
(m, 3H), 1.93 (s, 3H), 1.75 (m, lH), 1.55 (m, lH), 1.24 (m, lH), 1.12 (m, lH). 13C NMR 
b 169.47, 136.55, 134.01, 129.32, 129.14, 128.74, 127.66, 61.31, 60.82, 53.31, 48.10, 
30.20, 28.84, 27.77, 19.72. 
1-Benzyl-5-(phenylsulfonyl)-6-[propan-3-al]-2-piperidinone (26). Lactam 25 (0.081 g; 
0.21 mmol) was dissolved in 7 mL of CH2Cl2 and added to pyridinium chlorochromate 
(PCC) (0.085 g; 0.39 mmol) in 15 mL of CH2Cl2• After 4 h the reaction was filtered and 
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the solvent removed in vacuo. The residue was taken up in ether and extracted with 
Na2CO3 solution. The organic layer was dried over MgSO4 and the solvent removed in 
vacuo. Column chromatography (ethyl acetate) yielded 60 mg (67%) as a light yellow 
oil. Anal. Calcd for Cz1H23NO4S: C, 65.43; H, 6.01; N, 3.63. Found C, 65.29; H, 5.93; 
N, 3.57. Rf= 0.35 (ethyl acetate). IR 1730 cm-1 (strong). 1H NMR o 9.55 (s, lH), 7.60 
(t, J = 5.1 Hz, 2H), 7.48 (m, 3H), 7.35 (s, SH), 5.20 (d, J = 14.8 Hz, 2H), 4.10 (d, J = 
14.7 Hz, 2H), 3.73 (m, 2H), 3.17 (m, lH), 2.74 (m, lH), 2.25 (m, 2H), 1.71 (m, 2H). 13C 
NMR o 199.64, 169.99, 136.40, 134.12, 129.39, 129.11, 128.75, 128.69, 128.62, 127.78, 
61.18, 53.12, 48.38, 39.06, 28.96, 26.32, 20.67, 19.42. 
1-Benzyl-5-(phenylsulfonyl)-6-(3-hydroxyheptane)-2-piperidinone (27). Magnesium 
turnings (0.015 g; 0.60 mmol) were suspended in 7 mL of dry ether and 1-bromobutane 
(0.09 g; 0.65 mmol) in 4 mL of dry ether were combined. To the resulting solution, 
aldehyde 26 (0.051 g; 0.13 mmol) was added in lmL of dry ether. After 1 h the reaction 
was quenched with 1 mL H2O, extracted twice with CH2Cl2 and the organic layer was 
dried over Na2SO4• The solvent was removed in vacuo. Column chromatography (9:1, 
ethyl acetate/ether) yielded 52 mg (90%) as a clear oil. Anal. Calcd for C25H33NO4S: C, 
67.69; H, 7.50; N, 3.16. Found: C, 67.91; H, 7.59; N, 3.28. Rf= 0.58 (ethyl acetate). 
IR 3340 cm-1 (weak), 1730 cm-1 (strong). 1H NMR o 7.60 (t, J = 6.1 Hz, 2H), 7.43 (m, 
3H), 7.33 (bs, SH), 4.12 (m, 4H), 3.21 (m, lH), 2. 75 (m, lH), 2.21 (m, lOH), 1.32 (m, 
4H), 0.87 (t, J = 7.2 Hz, 3H). 13C NMR o 170.32, 136.31, 134.03, 129.37, 129.06, 
128.71, 128.63, 128.57, 127.80, 71.43, 60.41, 53.72, 48.39, 39.01, 37.26, 28.55, 22.55, 
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20.79, 19.31, 16.52, 14.12. 
1-Benzyl-6-[3-hydroxypropyl]-2-piperidinone (28). Lactam 25 (0.342 g; 0.29 mmol) 
was dissolved in 3 mL of methanol. Na/Hg (6%) was added until TLC showed 
consumption of starting material but generally the reaction was stirred at room 
temperature for 15 h. The reaction was then filtered and the solvent removed in vacuo 
to yield 0.153 g (47%) of a colorless oil. Anal. Calcd. for C15H21NO2: C, 72.84; H, 8.12; 
N, 5.66. Found: C, 72.89; H, 8.12; N, 5.02. Rf= 0.11 (ethyl acetate). IR 3445 cm-1• 
1H NMR o 7.33-7.20 (m, 5H), 5.38 (d, J = 15.1 Hz, 2H), 4.25 (m, lH), 3.92 (m, lH), 
3.60 (t, J = 5.6 Hz, 2H), 3.29 (m, lH), 2.50 (t, J = 6.1 Hz, 2H), 1.92-1.37 (m, 7H). 13C 
NMR o 170.52, 137.11, 128.54, 128.45, 127.59, 127.52, 127.17, 62.04, 55.11, 47.48, 
31.39, 28.72, 28.08, 25.90, 16.79. 
1-Benzyl-6-[3-hydroxypropyl]-piperidine (30). Piperidine 30 was isolated as a less 
polar side product in the synthesis of 28. Anal. Calcd for C15H23NO: C, 77.21; H, 9.93; 
N, 6.00. Found: C, 77.57; H, 9.68; N, 5.92. Rf= 0.05 (ethyl acetate). IR 3450cm-1• 1H 
NMR o 7.34-7.20 (m, 5H), 5.38 (d, J = 15.1 Hz, 2H), 4.61 (bs, lH), 3.96 (m, lH), 3.59 
(t, J = 6.4 Hz, 2H), 3.32 (m, lH), 2.51 (t, J = 5.6 Hz, 2H), 1.91-1.40 (m, 9H). 13C NMR 
o 137.15, 128.65, 128.56, 127.68, 127.62, 127.29, 62.04, 55.26, 47.62, 31.43, 28.77, 
28.22, 28.14, 25.97, 16.84. 
y-Octanoic lactol (32). y-Octanoic lactone (2.0 g; 14.06 mmol) in 100 mL of ether at -78 
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~C was reacted with DIBAL-H (28 mL; 0.5 M in hexane). The reaction was stirred at -78 
~C for 4 h and allowed to warm to room temperature overnight. An equal volume of a 
1 % NaOH solution was added and stirred for 10 min. The aqueous layer was extracted 
thrice with ether, dried over MgSO4 and the solvent removed in vacuo. Column 
chromatography (1:1, diethyl ether/petroleum ether) yielded 0.487 g of a clear oil (25%). 
Anal. Calcd for CgH16O2: C, 66.63; H, 11.19. Found: C, 66.59; H, 11.16. Rf= 0.23 (1:1, 
diethyl ether/petroleum ether). IR 3425 cm·1 (strong). 1H NMR {) 4.47 (m, 2H), 2.51 (m, 
2H), 2.32 (m, lH), 1.94 (m, 2H), 1.63 (m, 2H), 1.38 (m, 4H), 0.88 (t, J = 6.9 Hz, 3H). 
13C NMR o 177.21, 80.98, 35.21, 28.80, 27.95, 27.28, 22.37, 13.85. 
N-Benzyl-2-amino-5-butyl-tetrahydrofuran (34). Lactol 32 (0.037 g; 0.26 mmol) was 
dissolved in 1 mL of toluene and added to a stirring solution of benzylamine (0.031 g; 
0.27 mmol) in 1.5 mL of toluene. The reaction was stirred at room temperature for 48 
h. At this time, the solvent was removed in vacuo and the benzyl amine removed by 
further warming to 50 °C to yield 52.9 mg (87%), of product. Anal. Calcd for C15H23NO: 
C, 77.21; H, 9.93; N, 6.00. Found: C, 76.86; H, 9.68; N, 5.64. Rr = 0.64 (ethyl acetate). 
IR 3385 cm·1 (strong), 1660 cm·1 (weak), 1595 cm·1 (strong). 1H NMR o 7.44-7.18 (m, 
5H), 4.87 (t, J = 6.8 Hz, lH), 4.72 (t, J = 6.8 Hz, lH), 4.05 (m, 2H), 3.89 (m, 4H), 2.20 
(m, lH), 2.01 (m, lH), 1.77-1.22 (m, 4H), 0.91 (t, J = 7.1 Hz, 3H). 13C NMR o 128.55, 
128.32, 128.19, 126.82, 126.74, 78.41, 49.79, 36.58, 32.71, 31.85, 30.29, 28.39, 22.82, 
14.07. 
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1-Benzy 1-6-(3-be nzy loxypro py 1)-2-ethoxy-5-(p he ny lsulfony I) pip eridinium 
tetrafluoroborate (37). Triethyloxonium tetrafluoroborate (0.123 g; 0.83 mmol) was 
added to a stirring solution of lactam 10 (0.26 g; 0.54 mmol) in 5mL CH2Cl2• The 
reaction was stirred for 24 h and then the solvent was removed in vacuo to yield 293 mg 
of product (87%). Rf= 0.50. IR 3420 cm-1 (weak) 1110 cm-1 (strong) 1000 cm-1 (strong). 
1H NMR 7.67 (t, J = 5.2 Hz, 2H), 7.40 (m, 3H), 7.31 (m, lOH), 4.38 (m, 4H), 3.99 (t, 2H, 
J = 6.8 Hz), 3.38 (m, 4H), 3.11 (m, lH), 2.60 (m, lH), 2.21 (m, 2H), 1.98 (m, lH), 1.45 
(m, lH), 1.27 (m, lH), 1.24 (t, J = 7.0 Hz, 3H). 13C NMR 176. 75, 136.82, 135.34, 
134.70, 131.27, 129.94, 129.85, 129.68, 129.61, 129.24, 129.13, 129.06, 128.52, 128.41, 
128.36, 128.13, 128.08, 72.99, 68.45, 60.13, 56.35, 56.25, 52.21, 48.69, 38.43, 27.82, 
25.08, 22.54. 
1-Benzyl-2-[3-benzyloxypropyl]-3-(phenylsulfonyl)piperidine (39). Lactam 10 (1.56 
g; 3.27 mmol) was dissolved in 7 mL of THF and cooled to O °C in an ice bath. BH3-
THF (10 mL; 1.0 M in THF) was slowly added and stirred for 1.5 h. The reaction was 
allowed to warm to room temperature and the excess borane was hydrolyzed with 10% 
NaOH (careful addition is necessary as the reaction is very vigorous). Partitioning 
between ethyl acetate and Na2CO3 followed by drying the organic layer over MgSO4 and 
solvent removal in vacuo yields 39 (1.32 g, 87%) as the sole product. Anal. Calcd for 
CzgH33NO3S: C, 72.53; H, 7.17; N, 3.02. Found: C, 72.48; H, 7.21; N, 2.98. 
39 (fast band): Rf= 0.59 (ethyl acetate). 1H NMR o 7.89 (d, J = 2.8 Hz, 2H), 
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7.64 (t, J = 2.9 Hz, lH), 7.55 (t, J = 2.9 Hz, 2H), 7.30 (m, lOH), 4.50 (m, 2H), 3.72 (q, 
2H J = 12.8 Hz), 3.45 (m, 4H), 3.28 (m, lH), 2.49 (m, 2H), 2.10-1.20 (m, 7H). 13C NMR 
o 139.12, 133.34, 129.24, 129.04, 129.01, 128.74, 128.61, 128.24, 128.17, 127.60, 127.53, 
127.42, 127.34, 126.98, 72.89, 70.41, 61.46, 56.91, 42.53, 30.39, 27.33, 22.11, 20.86, 
20.36. 
39 (slow band): Rr = 0.55 (ethyl acetate). 1H NMR o 7.84 (d, J = 3.1 Hz, 2H), 
7.58 (t, J = 3.0 Hz, lH), 7.46 (t, J = 3.0 Hz, 2H), 7.30 (m, lOH), 4.44 (s, 2H), 3.67 (m, 
2H), 3.38 (m, 4H), 3.08 (m, lH), 2.47 (m, 2H), 2.14-1.30 (m, 7H). 13C NMR o 139.01, 
138.17, 132.96, 128.72, 128.40, 128.34, 128.05, 127.91, 127.29, 127.23, 126.54, 72.68, 
69.53, 60.13, 56.83, 45.14, 26.49, 22.07, 20.89, 20.59, 20.31. 
1-Benzyl-6-[3-benzyloxypropyl]piperidine (41). Piperidine 39 (1.25 g; 2. 71 mmol) was 
dissolved in 10 mL of methanol and 6% Na/Hg was added in excess. The reaction was 
stirred at room temperature for 16 h. The reaction mixture was filtered and the solvent 
removed in vacuo. Flash chromatography (ethyl acetate) yielded two products 0.62 g of 
41 (77% yield) and 0.18 g of 42 (20% yield). Anal. Calcd for (;2H29NO: C, 81.69; H, 
9.23; N, 4.33. Found: C, 81.85; H, 9.23; N, 4.40. (less polar) Rr = 0.12 (ethyl acetate). 
1H NMR o 7.30 (m, lOH), 4.50 (s, 2H), 3.98 (d, J = 5.2 Hz, lH), 3.48 (m, 2H), 3.22 (d, 
J = 5.1 Hz, lH), 2.76 (m, lH), 2.31 (m, lH), 2.04 (m, lH), 1.71 (m, 6H), 1.46 (m, 3H), 
1.30 (m, lH). 13C NMR o 138.56, 128. 77, 128.22, 127.98, 127.48, 127.35, 126.48, 72.81, 
70.76, 60.41, 57.57, 51.66, 30.22, 28.21, 25.66, 25.19, 23.73. 
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1-Benzyl-8-benzyloxy-oct-4-ene (42). Polar product from reaction of 39 with 6% Na/Hg. 
Anal. Calcd for c;2H29NO: C, 81.69; H, 9.04; N, 4.33. Found: C, 81.57; H, 8.96; N, 
4.40. Rr = 0.33 (ethyl acetate). 1H NMR o 7.38 (m, lOH), 5.51 (m, 2H), 4.59 (s 2H), 
3.87 (s, 2H), 3.56 (m, 3H), 2.72 (t, J = 7.0 Hz, 2H), 2.16 (m, 3H), 1.78 (m, 2H), 1.67 (m, 
2H), 1.31 (m,lH). 13C NMR o 140.33, 138.47, 130.10, 129.75, 128.15, 128.13, 127.89, 
127.39, 127.26, 126.65, 72.74, 69.62, 53.98, 48.83, 30.30, 29.83, 29.57, 29.09. 
1-Benzyl-6-[3-benzyloxypropyl]-2-piperidinone (43). A mixture of both diastereomers 
of 10 (2.17 g; 4.55 mmol) were dissolved in 16 mL of methanol and an excess 6% Na/Hg 
was added. After 3 h the reaction was filtered and the solvent removed in vacuo. Flash 
chromatography (9:1 ethyl acetate/diethyl ether) yields 1.53 g (89%) of a colorless oil. 
Anal. Calcd for c;2H27NO2: C, 78.30; H, 8.07; N, 4.15. Found: C, 78.28; H, 8.13; N, 
4.19. Rr = 0.32 (ethyl acetate). 1H NMR o 7.28 (m, lOH), 5.38 (d, J = 14.9 Hz, 2H), 
4.48 (s, 2H), 3.92 (d, J = 15.1 Hz, 2H), 3.42 (t, J = 6.2 Hz, 2H), 3.28 (m, lH), 2.48 (m, 
2H), 1.98-1.23 (m, 6H). 13C NMR o 170.13, 138.23, 137.63, 128.40, 128.29, 127.63, 
127.51, 127.48, 127.01, 73.00, 69.79, 55.17, 47.39, 32.04, 28.85, 26.33, 26.22, 17.37. 
1-Benzyl-5-methyl-6-[3-benzyloxypropyl]piperidine (44). Piperidine ( 41) (0.055 g; 0.17 
mmol) was dissolved in 3 mL CH2Cl2 and cooled to -15 °C in an ice salt bath . .m-CPBA 
(0.059 g; 0.34 mmol) in 5 mL of CH2Cl2 was added slowly and stirred for 0.5 h. The ice 
bath was removed and the reaction cooled to -78 °C and TFM (0.082 g; 0.39 mmol) was 
added and the reaction stirred an additional 0.5 h. Methyllithium (0.2 mL; 1.0 M in 
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hexane) was carefully added and the reaction allowed to warm to room temperature. 
Partitioning between ethyl acetate and Na2CO3, drying of the organic layer over MgSO4 
and solvent removal in vacuo provides the crude product. Flash chromatography (6:4, 
diethyl ether/petroleum ether) yields 0.006 g (11 %) as a yellow oil. Rf= 0.36 (diethyl 
ether). 1H NMR o 7.31 (m, lOH), 4.53 (s, 2H), 4.00 (d, J = 15.5 Hz, lH), 3.50 (m, lH), 
3.20 (d, J = 15.6 Hz, lH), 2.80 (m, lH), 2.32 (m, lH), 2.05 (m, lH), 1.65 (m, 6H), 1.46 
(m, 3H), 1.32 (m, lH), 1.07 ( d, J = 6.9 Hz, 3H). 
1-Benzyl-5-cyano-6-[3-benzyloxypropyl]piperidine (45). Piperidine 41 (0.171 g; 0.53 
mmol) was dissolved in 3 mL CH2Cl2 and cooled to -15 °C in an ice salt bath. m-CPBA 
(0.184 g; 1.07 mmol) in 5 mL of CH2Cl2 was added slowly and the reaction stirred for 
0.5 h. The ice bath was removed, TFM (0.225 g; 1.07 mmol) was added and the 
reaction stirred an additional 0.5 h. KCN (0.070 g; 1.07 mmol) in 5 mL of H2O was 
added and the reaction allowed to warm to room temperature. Partitioning between ethyl 
acetate and saturated Na2CO3, drying of the organic layer over MgSO4, and solvent 
removal in vacuo provided the crude product. Flash chromatography (6:4, diethyl 
ether/petroleum ether) yielded 45 (0.030 g, 17%) as a yellow oil. Rf = 0.70 (diethyl 
ether). 1H NMR o 7.30 (m, lOH), 4.51 (s, 2H), 3.96 (d, J = 15.9 Hz, lH), 3.61 (m, lH), 
3.23 (d, J = 16.1 Hz, lH), 3.05 (m, lH), 2.33 (m, lH), 2.08 (m, lH), 1.70 (m, 6H), 1.42 
(m, 3H), 1.28 (m, lH). 
1-Benzyl-5-(phenylsulfonyl)-6-[3-benzyloxypropyl]piperidin-2-thione (47). Lawesson's 
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reagent (1.30 g; 3.22 mmol) was added to lactam 10 (3.08 g; 6.45 mmol) in 12 mL of 
toluene and refluxed for 4 h. The solvent was removed in vacuo, and the mixture flash 
chromatographed (95:5, methylene chloride/ethyl acetate) to yield 3.05 g (96%) of the 
thiolactam 47 as a gold oil. Anal. Calcd for CisH31NO3S2·1/2 H2O: C, 66.89; H, 6.41; N, 
2.78. Found: C, 66.80; H, 6.34; N, 2.78. 
47 (fast band): Rr = 0.32 (ethyl acetate). 1H NMR {) 7.64 (m, 3H), 7.46 (t, J = 
5.7 Hz, 2H), 7.28 (m, lOH), 6.53 (d, J = 14.3 Hz, lH), 4.52 (s, 2H), 4.10 (d, J = 14.3 Hz, 
lH), 4.01 (m, lH), 3.50 (t, J = 6.1 Hz, 2H), 3.39 (m, lH), 3.19 (m, lH), 3.00 (m, lH), 
2.34 (m lH), 2.22 (m lH), 1.93 (m, 2H), 1.78 (m, 2H). 13C NMR {) 199.63, 138.05, 
137.78, 134.62, 133.92, 129.34, 128.77, 128.34, 128.24, 128.13, 127.84, 127.67, 127.59, 
73.15, 69.69, 62.85, 58.02, 57.42, 38.53, 27.39, 26.70, 17.34. 
47 (slow band): Rr = 0.29 (ethyl acetate). 1H NMR {) 7.60 (m, 3H), 7.47 (t, J = 
4.2 Hz, 2H), 7.32 (m, lOH), 5.86 (d, J = 14.4 Hz, lH), 4.77 (d, J = 14.7 Hz, lH), 4.41 
(s, 2H), 4.04 (m, lH), 3.31 (m, 4H), 2.81 (m, lH), 2.03 (m, 2H), 1.72 (m, lH), 1.67 (m, 
lH), 1.41 (m, lH), 1.26 (m, lH). 13C NMR b 201.08, 137.95, 136.61, 134.87, 134.05, 
129.31, 128.98, 128.72, 128.66, 128.37, 127.68, 127.54, 73.08, 68.72, 61.91, 56.13, 55.95, 
39.23, 31.58, 25.26, 20.13. 
1-Benzyl-6-[3-benzyloxypropyl]piperidin-2-thione (47H). Lawesson's reagent (0.998 
g; 2.47 mmol) was added to lactam 10 (1.66 g; 4.93 mmol) in 8 mL of toluene and 
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refluxed for 4 h. The solvent was removed in vacuo, and the mixture flash 
chromatographed ( 48:2:50, methylene chloride/acetonitrile/hexane) to yield 1. 70 g (98%) 
of the thiolactam 47H as a gold oil. Anal. Calcd for ½2H27NOS: C, 74.74; H, 7.70; N, 
3.96. Found: C, 74.78; H, 7.90; N, 3.94. Rf= 0.38 (ethyl acetate). 1H NMR c> 7.31 (m 
lOH), 6.47 (d, J = 14.9 Hz, lH), 4.48 (s 2H), 4.32 (d, J = 14.9 Hz, lH), 3.47 (m 4H), 
3.15 (t, J = 5.8 Hz, 2H), 1.85 (m 2H), 1. 72 (m, 4H), 1.66 (m, lH). 13C NMR c> 200.96, 
138.10, 135.61, 128.60, 128.34, 127.59, 127.51, 127.49, 73.10, 69.47, 58.07, 55.37, 41.14, 
28.70, 26.47, 25.84, 17.05. 
1-Benzyl-5-(phenylsulf onyl)-6-[benzyloxypropyl]-2-[ ( ethoxycarbonyl)methylidene] 
piperidine (11). Thiolactam 47 (2. 77 g; 5.61 mmol) in 7 mL dry acetonitrile was stirred 
at room temperature with ethyl bromoacetate (1.17 g; 7.01 mmol) for 48 h. The reaction 
was then diluted with 24 mL of CH2Cl2 and after 10 minutes, triphenylphosphine (3.31 
g; 12.62 mmol) was added and stirred an additional 0.5 h. Triethylamine (1.70 g; 16.83 
mmol) was then added and the reaction stirred for an additional 24 h. The mixture was 
diluted with ethyl acetate (30 mL), washed with saturated Na2CO3, brine, and dried over 
MgSO4• Flash chromatography (9:1, methylene chloride/ethyl acetate) yielded 2.89 g 
(94%) of 11 as a gold oil. Anal. Calcd for ½2H37NO5S·l/2 H2O: C, 69.04; H, 6.88; N, 
2.52. Found: C, 69.09; H, 6. 75; N, 2.49. 
11 (fast band): Rf= 0.45 (diethyl ether). IR 1755 cm-1• 1H NMR c> 7.77 (d, J = 
5.4 Hz, 2H), 7.63 (t, J = 5.4 Hz, lH), 7.50 (t, J = 2.3 Hz, 2H), 7.28 (m, lOH), 4.72 (s, 
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2H), 4.43 (m, 3H), 4.22 (m, 2H), 4.01 (m, 2H), 3.87 (m, lH), 3.71 (m, lH), 3.33 (m, 4H), 
2.23 (m, lH), 1.92 (m, lH), 1.68 (m, 2H), 1.45 (m, lH), 1.22 (m, 3H). 13C NMR () 
168.46, 160.96, 135.78, 133.90, 129.21, 128.85, 128.57, 128.30, 127.52, 127.35, 88.09, 
73.02, 69.30, 63.77, 58.60, 55.92, 55.13, 33.26, 25.47, 23.36, 20.34, 14.62. 
11 (slow band): Rr = 0.42 (diethyl ether). IR 1750 cm·1• 1H NMR () 7.75 (d, J 
= 5.1 Hz, 2H), 7.64 (t, J = 5.4 Hz, lH), 7.52 (t, J = 2.1 Hz, 2H), 7.26 (m, lOH), 4.69 (s, 
lH), 4.43 (m, 3H), 4.20 (m, 2H), 4.01 (m, 2H), 3.86 (m, lH), 3.34 (m, 4H), 2.23 (m, lH), 
1.95 (m, lH), 1.56 (m, 4H), 1.19 (t, J = 7.1 Hz, 3H). 13C NMR () 168.28, 160.80, 138.02, 
136.69, 135.68, 133.79, 129.09, 128.69, 128.16, 127.37, 127.35, 127.20, 87.94, 72.84, 
69.15, 63.55, 58.43, 55.86, 54.98, 33.09, 25.31, 23.20, 20.16, 14.50. 
1-Benzyl-6-[benzyloxypropyl]-2-[( ethoxycarbonyl)methy lidene] piperidine (l lH). 
Thiolactam 47H (1.45 g; 4.11 mmol) in 7 mL dry acetonitrile was stirred at room 
temperature with ethyl bromoacetate (0.859 g; 5.14 mmol) for 48 h. The reaction was 
then diluted with 22 mL of CH2Cl2 and after 10 minutes, triphenylphosphine (1.62 g; 6.17 
mmol) was added and stirred an additional 0.5 h. Triethylamine (1.25 g; 12.33 mmol) 
was then added and the reaction stirred for an additional 24 h. The mixture was diluted 
with ethyl acetate (30 mL), washed with saturated Na2CO3, brine and dried over MgSO4• 
Flash chromatography (95:5, methylene chloride/ethyl acetate) yielded 1.52 g (91 %) of 
llH as a gold oil. Anal. Calcd for Ci6H33NO3: C, 76.62; H, 8.16; N, 3.44. Found: C, 
76.81; H, 7.94; N, 3.31. Rr = 0.55 (diethyl ether). IR 1750 cm·1• 1H NMR () 7.29 (m, 
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SH), 7.13 (d, J = 6.8 Hz, 2H), 4.51 (m, 4H), 4.27 (d, J = 16.9 Hz, lH), 4.40 (m, 2H), 
3.41 (t, J = 6.1 Hz, 2H), 3.26 (m, 2H), 3.13 (m, 2H), 1.70 (m, 6H), 1.47 (m, lH), 1.17 
(t, 3H, J = 7.1 Hz). 13C NMR b 168.83, 162.10, 138.21, 136.50, 128.49, 128.26, 127.47, 
126.90, 126.39, 84.22, 72.97, 68.80, 58.23, 58.12, 53.75, 29.72, 26.60, 26.54, 26.44, 
16.24, 14.73. 
1-Benzyl-5-(phenylsulf onyl)-6-[hydroxypropyl]-2-[( ethoxycarbonyl)methylidene] 
piperidine (51). TMS-1 (0.464 g; 2.23 mmol) was added to slow vinylogous carbamate 
11 (0.554; 1.10 mmol) in 3 mL of CH2Cl2 at 0 °C and the reaction was stirred for 6 h. 
The mixture was diluted with 15 mL of CH2Cl2 and 5 mL of sodium bisulfite was added 
to hydrolyze the excess TMS-1. The organic layer was washed with brine and dried over 
MgSO4• Flash chromatography (9:1, diethyl ether/petroleum ether) gave 0.374 g (81 %) 
of 51 as a yellow oil. Anal. Calcd for Ci5H31NO5S: C, 65.62; H, 6.83; N, 3.06. Found: 
C, 65.39; H, 6.76; N, 2.98. Rr = 0.17 (diethyl ether). IR 3485 cm-1• 1H NMR b 7.76 (d, 
J = 6.2 Hz, 2H), 7.64 (t, J = 6.0 Hz, lH), 7.51 (t, J = 5.5 Hz, 2H), 7.33 (m, 5H), 4.71 (s, 
lH), 4.28 (m, 3H), 3.99 (m, 2H), 3.93 (m, lH), 3.51 (t, J = 6.0 Hz, 2H), 3.32 (m, lH), 
2.18 (m, lH), 1.94 (m, 3H), 1.67 (m, 2H), 1.40 (m, 2H), 1.18 (t, J = 7.1 Hz, 3H). 13C 
NMR b 168.44, 160.93, 136.65, 135.72, 133.95, 129.21, 128.79, 128.53, 127.47, 127.33, 
88.10, 63.78, 61.78, 58.58, 55.82, 55.04, 32.92, 27.97, 23.35, 20.39, 14.55. 
1-Benzyl-5-(phenylsulfonyl)-6-[benzyloxypropyl]-2-[( ethoxycarbonyl)methyl]-
piperidine (52). Vinylogous carbamate 11 (1.08 g; 1.97 mmol) was dissolved in 7 mL 
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of methanol and the pH was adjusted to 4 with acetic acid. NaCNBH3 (0.124 g; 1.97 
mmol) was added and the reaction bubbled and became warm. After 3 h the reaction 
mixture was diluted with ethyl acetate and washed with 20% NaOH, saturated NaHCO3 
and brine. The solvent was removed in vacuo to provide 1.05 g pure 52 in 97% yield. 
Anal. Calcd for ½2H39NO5S: C, 69.91; H, 7.15; N, 2.55. Found: C, 69.87; H, 7.11; N, 
2.50. 
52 (fast band): Rf= 0.60 (diethyl ether). IR 1730 cm-1• 1H NMR o 7.88 (m, 2H), 
7.53 (m, SH), 7.29 (m, 8H), 4.55 (m, 3H), 4.10 (m, 2H), 3.80 (m, lH), 3.63 (m, lH), 3.50 
(m, 4H), 3.29 (m, lH), 2.77 (m, lH), 2.46 (m, lH), 1.96 (m, 4H), 1.65 (m, 2H), 1.34 (m, 
lH), 1.28 (t, J = 7.1 Hz, 3H). 13C NMR b 169.96, 139.05, 133.28, 129.31, 129.02, 
128.98, 128.73, 128.41, 128.35, 128.30, 128.24, 128.19, 128.16, 128.09, 128.05, 127.79, 
127.63, 127.54, 127.51, 127.31, 127.26, 126.90, 72.79, 70.32, 61.32, 57.84, 56.78, 52.37, 
42.46, 29.16, 27.24, 22.04, 20.77, 20.28, 18.51. 
52 (slow band): Rr = 0.55 (diethyl ether). IR 1725 cm-1• 1H NMR b 7.80 (d, J 
= 7.3 Hz, 2H), 7.61 (t, J = 7.3 Hz, lH), 7.50 (t, J = 7.9 Hz, 2H), 7.30 (m, lOH), 4.42 (s, 
2H), 4.08 (m, 2H), 3.77 (q, J = 14.1 Hz, 2H), 3.42 (m, 2H), 3.31 (m, 3H), 3.01 (m, lH), 
2.57 (m, lH), 2.34 (m, lH), 2.03 (m, lH), 1.84 (m, 2H), 1. 70 (m, 2H), 1.59 (m, lH), 1.45 
(m, lH), 1.23 (t, J = 7.5 Hz, 3H). 13C NMR b 171.67, 139.46, 138.52, 138.49, 133.31, 
129.00, 128.60, 128.52, 128.21, 128.13, 127.51, 127.34, 126.83, 72.78, 69.81, 61.53, 
60.45, 54.38, 51.48, 50.67, 38.49, 27.11, 26.37, 23.16, 21.09, 14.23. 
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1-Benzyl-6-[benzyloxypropyl]-2-[(ethoxycarbonyl)methyl]-piperidine (52H). 
Vinylogous carbamate llH (1.32 g; 3.24 mmol) was dissolved in 7 mL of methanol and 
the pH was adjusted to 4 with acetic acid. NaCNBH3 (0.204 g; 3.24 mmol) was added 
and the reaction bubbled and became warm. After 3 h, the reaction mixture was diluted 
with ethyl acetate and washed with 20% NaOH, saturated NaHCO3 and brine. The 
solvent was removed in vacuo to provide 1.29 g pure 52H in 97% yield. Anal. Calcd for 
½6H35NO3: C, 70.71; H, 7.99; N, 3.17. Found: C, 70.32; H, 8.00; N, 3.57. Rr = 0.74 
(diethyl ether) 1H NMR o 7.27 (m, lOH), 4.44 (s, 2H), 4.09 (m, 2H), 3.70 (m, 4H), 3.32 
(m, 3H), 2.77 (m, lH), 2.62 (m, lH), 2.36 (m, lH), 1.64 (m, SH), 1.38 (m, 3H), 1.22 (m, 
3H). 13C NMR o 168.83, 141.s1, 138.21, 128.67, 128.31, 127.59, 126.98, 126.43, 73.12, 
71.02, 60.84, 54.87, 52.91, 50.99, 38.01, 29.17, 27.55, 25.89, 25. 78, 22.08, 14.67. 
5-(Phenylsulfonyl)-6-[hydroxypropy l]-2-[ ( eth oxycarbonyl)methyl] piperidin e ( 53). 
Piperidine 52 (1.18 g; 2.14 mmol) was dissolved in 4 mL of ethanol and excess Raney-
Nickel W-2 was added. The reaction was stirred for 6 h and an additional portion of 
Raney-Nickel was added followed by stirring for 18 h. The reaction was filtered through 
Celite and the solvent removed in vacuo. The organic residue was dissolved in 40 mL 
of ethyl acetate and washed with H2O, saturated Na2CO3, and brine, then dried over 
MgSO4 and the solvent removed in vacuo to yield 0.657 g (83%) of 53 as a colorless oil. 
Anal. Calcd for C18H27NO5S: C, 59.51; H, 7.37; N, 3.79. Found: C, 59.19; H, 7.65; N, 
3.54. 
107 
53 (fast band): Rf= 0.15 (diethyl ether). 1H NMR o 7.88 (d, J = 5.2 Hz, 2H), 
7.68 (t, J = 5.1 Hz, lH), 7.59 (t, J = 5.9 Hz, 2H), 4.12 (m, lH), 3.68 (m, lH), 3.53 (m, 
lH), 3.31 (m, lH), 3.24 (m, lH), 2.94 (m, lH), 2.73 (m, 2H), 2.61 (m, 2H), 2.32 (m, lH), 
1.94 (m, 4H), 1.18 (m, lH), 1.61 (m, 2H), 1.52 (m, lH), 1.07 (t, J = 7.2 Hz, 3H). BC 
NMR o 133.58, 129.16, 128.98, 128.28, 63.01, 60.29, 57.76, 46.73, 41.99, 31.84, 25.16, 
20.36, 19.80, 13.18. 
53 (slow band): Rf= 0.12 (diethyl ether). IR 3505 cm-1• 1H NMR o 7.88 (d, J 
= 4.9 Hz, 2H), 7.66 (t, J = 4.1 Hz, lH), 7.58 (t, J = 4.9 Hz, 2H), 4.14 (m, 3H), 3.55 (m 
4H), 3.27 (m, 2H), 2.84 (m, lH), 2.43 (m, lH), 2.24 (m, lH), 2.01 (m, 2H), 1.70 (m 3H), 
1.43 (m, lH), 1.27 (t, J = 7.2 Hz, 3H). BC NMR o 171.43, 137.67, 133.73, 129.26, 
128.33, 62.40, 61.10, 60.67, 50.64, 45.89, 41.01, 30.84, 30.76, 26.77, 19.77, 14.26. 
6-[Hydroxypropyl]-2-[(ethoxycarbonyl)methyl]piperidine (53H). Piperidine 52H (1.01 
g; 2.48 mmol) was dissolved in 4 mL of ethanol and excess Raney-Nickel W-2 was 
added. The reaction was stirred for 6 h and an additional portion of Raney-Nickel was 
added followed by stirring for 18 h. The reaction was filtered through Celite and the 
solvent removed in vacuo. The organic residue was dissolved in 40 mL of ethyl acetate 
and washed with H2O, saturated Na2CO3, and brine, then dried over MgSO4 and solvent 
removed in vacuo to yield 0.232 g ( 41 % ) of 53H as a colorless oil. HRMS m/z Calcd 
for C12H23NO3: 228.1600, found: 228.1599. Rf= 0.15 (diethyl ether). IR 3495 cm-1• 1H 
NMR 4.14 (m, 2H), 3.58 (m, 3H), 2.96 (m, lH), 2.62 (m, lH), 2.41 (m, 2H), 1.84 (m, 
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2H), 1.73 (m, lH), 1.61 (m, 4H), 1.45 (m, 2H), 1.26 (t, J = 7.1 Hz, 3H), 1.16 (m, 2H). 
13C NMR 6 172.19, 62.85, 60.48, 56.44, 53.33, 41.09, 35.73, 31.74, 31.52, 29.70, 24.46, 
14.18. 
8-(Phenylsulfonyl)-5-[(ethoxycarbonyl)methyl]indolizidine (54). Piperidine 53 (0.025 
g; 0.07 mmol) was dissolved in 7 mL of THF and cooled to -78° C. Trifluoromethane 
sulfonic anhydride (0.022 g; 0.08 mmol) was added and stirred for 10 minutes. The -78 
°C bath was removed and triethylamine (0.018 g; 0.18 mmol) added and the reaction 
allowed to equilibrate to room temperature. The mixture was diluted with 10 mL of ethyl 
acetate and washed with saturated NaHCO3, and brine, then dried over MgSO4 and the 
solvent removed in vacuo. Flash chromatography (ethyl acetate) yielded 0.023 g (96%) 
of 54 as a colorless oil. Anal. Calcd for C18H25NO4S: C, 61.51; H, 7.17; N, 3.99. Found: 
C, 61.29; H, 7.27; N, 3.81. 
54 (fast band): Rr = 0.46 (diethyl ether). IR 2800 cm-1• 1H NMR 6 7.89 (d, J = 
5.3 Hz, 2H), 7.65 (t, J = 5.0 Hz, lH), 7.56 (t, J = 5.9 Hz, 2H), 3.28 (m, 2H), 2.57 (m, 
4H), 1.82 (m, 4H), 1.48 (m, 2H), 1.02 (m, 3H). 13C NMR 6 133.28, 129.04, 128.98, 
128.30, 62.11, 57.88, 4 7.58, 43.61, 21. 77, 20.63, 17.82, 13.96, 12.43. 
54 (slow band): Rr = 0.36 (diethyl ether). IR 2795 cm-1• 1H NMR b 7.89 (d, J 
= 4.0 Hz, 2H), 7.66 (t, J = 4.1 Hz, lH), 7.57 (t, J = 4.3 Hz, 2H), 4.10 (m 2H), 3.56 (m, 
lH), 3.45 (m, lH), 2.85 (m, 2H), 2.65 (m, lH), 2.51 (m, 2H), 2.28 (m, lH), 2.16 (m, lH), 
109 
1.70 (m, 6H), 1.25 (m, 3H). 13C NMR o 172.54, 138.04, 133.60, 129.02, 128.59, 66.84, 
60.54, 53.50, 51.35, 48.59, 30.44, 28.75, 27.92, 21.04, 20.70, 14.25. 
5-[(Methoxycarbonyl)methyl]indolizidine (55). Indolizidine 54 (0.358 g; 1.02 mmol) 
was dissolved in 5 mL of methanol and excess 6% Na/Hg added. The reaction was 
monitored by TLC for consumption of starting material. After 5 h, the mixture was 
filtered into 3 mL of methanolic HCl to capture the volatile indolizidine as the 
hydrochloride salt. The solvent was removed in vacuo followed by partitioning between 
diethyl ether and 20% KOH to liberate the free base. Removal of solvent yielded 0.080 
g of indolizidine 55 (38%). HRMS m/z Calcd for C11H19NO2: 197.1416, found: 197.1416. 
Rr = 0.38 (diethyl ether). IR 2765 cm-1• 1H NMR o 3.68 (s, 3H), 3.61 (m, lH), 2.88 (m, 
lH), 2.62 (m, lH), 2.42 (m, 4H), 1.88-1.12 (m, 7H). 13C NMR o 173.81, 54.99, 52.53, 
51.54, 49.03, 31.33, 30.60, 29.15, 28.81, 20.72, 19.29. 
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